4grm:B (HIS156) to (ALA245) THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6 | HIGH-AFFINITY TCR, C134 MODIFICATION, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM
4grw:D (ASP129) to (PHE205) STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS) | CYTOKINE, IMMUNOGLOBULIN FOLD, VHH DOMAIN, IMMUNE SYSTEM
3e6h:B (ILE35) to (TYR94) MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120 | COMPLEX (HISTOCOMPATIBILITY-ANTIGEN), GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, IMMUNE SYSTEM
3rl1:B (ILE35) to (LYS94) HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301 | HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM
3rl2:B (ILE35) to (LYS94) HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301 | HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM
1a1n:B (ILE35) to (LYS94) MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B3501, HIV, NEF, COMPLEX (ANTIGEN/PEPTIDE)
1a1o:B (ILE35) to (LYS94) MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, MALARIA, COMPLEX (ANTIGEN/PEPTIDE)
1n8z:B (PRO156) to (PRO220) CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB | TYROSIN KINASE RECEPTOR, CELL SURFACE RECEPTOR, TRANSFERASE
4wdi:B (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4wdi:E (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
1nan:I (HIS34) to (TYR94) MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE | CLASS I MHC, H-2KB, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM
4web:H (PRO154) to (PRO217) STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2 | HEPATITIS C VIRUS, E2, IGG-LIKE FOLD, SCAVENGER RECEPTOR CLASS B TYPE I (SR-BI), CD81, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
2ajz:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER | CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, HYDROLYTIC, IMMUNE SYSTEM
4gup:B (ASP34) to (LYS94) STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1 | MHC CLASS I-RELATED PROTEIN, IMMUNE SYSTEM
4gup:D (ASP34) to (LYS94) STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1 | MHC CLASS I-RELATED PROTEIN, IMMUNE SYSTEM
2akr:D (HIS34) to (TYR94) STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D | NKT CELLS, CD1D, MHC FOLD, SULFATIDE, SELF-ANTIGEN, TCR, IMMUNE SYSTEM
1nby:B (PRO449) to (ILE510) CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A | ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
1a6a:B (SER126) to (ARG189) THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 | MHC GLYCOPROTEIN, COMPLEX (TRANSMEMBRANE-GLYCOPROTEIN), COMPLEX (TRANSMEMBRANE-GLYCOPROTEIN) COMPLEX
1a6z:B (ILE35) to (LYS94) HFE (HUMAN) HEMOCHROMATOSIS PROTEIN | HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, MHC CLASS I COMPLEX
1a6z:D (ILE35) to (LYS94) HFE (HUMAN) HEMOCHROMATOSIS PROTEIN | HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, MHC CLASS I COMPLEX
1a9e:B (ILE36) to (ARG98) DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS | MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE)
3ecb:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120 | CLASS I MAJOR HISTOMPATIBILITY COMPLEX, MHC-I, H-2DD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, COILED COIL, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, LIPOPROTEIN, PALMITATE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
4wi9:A (LYS274) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi7:A (ASP376) to (LEU443) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
2oje:F (ILE127) to (ARG189) MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA | SUPERANTIGEN, MHC, IMMUNE SYSTEM
2arj:H (VAL152) to (PRO227) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
2arj:B (VAL152) to (PRO227) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
1ngy:B (PRO150) to (PRO214) CHIMERIC MATURE FAB 7G12-APO | ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM
4wj5:B (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE | ANTIGEN PRESENTATION, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-A2 ANTIGEN, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
4wj5:E (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE | ANTIGEN PRESENTATION, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-A2 ANTIGEN, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
2av1:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM
2av1:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM
2av7:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM
2av7:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM
3efd:H (PRO161) to (PRO225) THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA | HELIX BUNDLE, C-TERMINUS, IMMUNE SYSTEM
3eff:B (PRO160) to (PRO224) THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION | FULL LENGTH KCSA, BULGE HELIX, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE- GATED CHANNEL, MEMBRANE PROTEIN
1nj9:B (PRO148) to (LYS208) COCAINE HYDROLYTIC ANTIBODY 15A10 | IMMUNOGLOBULIN, IMMUNE SYSTEM
1agb:B (ILE35) to (LYS94) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1age:B (ILE35) to (LYS94) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
2axf:B (ASP34) to (LYS94) THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION | IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX
1aif:H (PRO157) to (ASP215) ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE | IMMUNOGLOBULIN, C REGION, V REGION
1akj:B (ILE35) to (LYS94) COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 | T-CELL, GLYCOPROTEIN, SIGNAL, COMPLEX, IMMUNOLOGY, COMPLEX (MHC I/PEPTIDE/CD8)
4wo4:B (ILE35) to (ASP98) THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION. | IMMUNITY, IMMUNE SYSTEM
3rwd:B (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwd:E (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwe:B (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-FW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwf:B (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-QW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwh:B (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwh:E (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwi:B (ILE35) to (LYS94) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-GW10 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
4h1l:B (SER126) to (ALA190) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBIN FOLD, TCR RECOGNITON OF MHC, MHC II, GLYCOSIDATION, MEMBRANE, IMMUNE SYSTEM
4h1l:E (SER126) to (ALA190) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBIN FOLD, TCR RECOGNITON OF MHC, MHC II, GLYCOSIDATION, MEMBRANE, IMMUNE SYSTEM
2b2x:I (PRO154) to (PRO217) VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB | COMPUTATIONAL DESIGN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4h20:H (PRO155) to (LYS215) CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18 | IG, ANTI RICIN ANTIBODY FAB FRAGMENT, RICIN A CHAIN, EXTRACELLULAR, BLOODSTREAM, IMMUNE SYSTEM
4h26:B (ILE127) to (ALA190) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, TCR, CELL SURFACE, IMMUNE SYSTEM
4h26:E (ILE127) to (ARG189) TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, TCR, CELL SURFACE, IMMUNE SYSTEM
1ao7:B (ILE35) to (LYS94) COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 | CLASS I MHC, T-CELL RECEPTOR, VIRAL PEPTIDE, COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR, COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR) COMPLEX
2osl:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE | FAB-PEPTIDE COMPLEX, RITUXIMAB, CHIMERIC ANTIBODY, IMMUNE SYSTEM
3ejy:C (PRO157) to (PRO220) STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
3ejz:C (PRO157) to (PRO220) STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
3eo9:H (PRO157) to (ASP216) CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB | EFALIZUMAB, FAB, ANTIBODY, IMMUNE SYSTEM
1axs:H (PRO149) to (PRO213) MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN | OXY-COPE, CATALYTIC ANTIBODY, FAB FRAGMENT
1axs:B (PRO149) to (PRO213) MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN | OXY-COPE, CATALYTIC ANTIBODY, FAB FRAGMENT
4wu5:B (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT) | IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
4wu5:E (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT) | IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
4wu7:E (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F) | IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
4wuu:B (ILE35) to (LYS94) STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1 | ANTIBODY, MHC 1, WT1, HLA-A*0201, IMMUNE SYSTEM
1b0r:B (ASP434) to (LYS494) CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP | HLA-A2, ANTIGENIC PEPTIDES, CLASS I MHC MOLECULES, HLA-A2 COMPLEXES, HYDROGEN BONDS, PROTEIN STRUCTURE, SIGNALING PROTEIN
4ww2:F (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8, BETA CHAIN- TRBV7-8, ANTIGEN-PRESENTING GLYCOPROTEIN CD1D, AND BETA-2- MICROGLOBULIN | NATURAL KILLER T CELLS, IMMUNITY, IMMUNE SYSTEM
4wwk:D (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV12-3, BETA CHAIN-TRBV6- 5, ANTIGEN-PRESENTING MOLECULE CD1D, AND BETA-2-MICROGLOBULIN | INNATE IMMUNITY, NKT, IMMUNE SYSTEM
2p5e:B (ILE35) to (LYS94) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2p5w:B (ILE35) to (ARG97) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2bem:C (ARG120) to (ASP192) CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21 | CHITIN-BINDING PROTEIN, CHITIN DEGRADATION, CHITIN-BINDING, FNIII-LIKE FOLD
2p8p:B (PRO150) to (PRO214) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC] | NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN
1bbj:H (PRO150) to (VAL212) CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS | IMMUNOGLOBULIN
1bbj:B (PRO150) to (VAL212) CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS | IMMUNOGLOBULIN
4hh9:D (PRO149) to (PRO213) ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 | FAB, ANTIBODY, IMMUNE SYSTEM
4x0k:H (PRO151) to (PRO227) ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE | ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM
4x0k:A (PRO151) to (PRO227) ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE | ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM
1bd2:B (ILE35) to (LYS94) COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 | COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR), COMPLEX (MHC-VIRAL PEPTIDE- RECEPTOR) COMPLEX
4hie:B (PRO149) to (VAL211) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hih:B (PRO149) to (GLU212) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE. | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hih:D (PRO149) to (GLU212) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE. | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
1bfo:B (PRO157) to (VAL216) CAMPATH-1G IGG2B RAT MONOCLONAL FAB | ANTIBODY, FAB, CAMPATH-1G, CD52
1bfo:D (PRO157) to (VAL216) CAMPATH-1G IGG2B RAT MONOCLONAL FAB | ANTIBODY, FAB, CAMPATH-1G, CD52
1bfo:F (PRO157) to (VAL216) CAMPATH-1G IGG2B RAT MONOCLONAL FAB | ANTIBODY, FAB, CAMPATH-1G, CD52
1bfo:H (PRO157) to (VAL216) CAMPATH-1G IGG2B RAT MONOCLONAL FAB | ANTIBODY, FAB, CAMPATH-1G, CD52
4hjg:B (PRO156) to (PRO220) MEDITOPE-ENABLED TRASTUZUMAB | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC
4hk0:B (THR147) to (PRO210) UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
3eyf:B (PRO161) to (PRO225) CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE | CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
3eyf:D (PRO161) to (GLU224) CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE | CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
4hkj:B (ASP34) to (LYS94) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:F (ASP34) to (LYS94) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:J (ASP34) to (LYS94) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:N (ASP34) to (LYS94) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkz:B (PRO156) to (PRO220) TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC
3ez8:A (GLN32) to (ARG85) CRYSTAL STRUCTURE OF ENDOGLUCANASE CEL9A FROM THE THERMOACIDOPHILIC ALICYCLOBACILLUS ACIDOCALDARIUS | BETA BARREL, (ALPHA/ALPHA)6 BARREL, GLYCOSIDASE, HYDROLASE
3s4s:E (SER126) to (ALA190) CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1 | PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM
2bnq:B (ILE35) to (LYS94) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES
4x5w:A (ASN118) to (PHE180) HLA-DR1 WITH CLIP102-120(M107W) | MHC II, IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP
4x5x:B (SER126) to (TRP188) HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W) | MHC II, IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP
4x5x:D (SER126) to (TRP188) HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W) | MHC II, IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP
3s6c:A (ILE1035) to (ARG1097) STRUCTURE OF HUMAN CD1E | MHC, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION, N- GLYCOSYLATION, INTRACELLULAR, LIPID BINDING PROTEIN
1bqh:B (HIS34) to (TYR94) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
1bqh:E (HIS34) to (TYR94) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
4x6c:D (ILE35) to (ASP98) CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6d:B (ASP34) to (TRP95) CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6d:D (ILE35) to (TRP95) CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6d:H (HIS155) to (ALA244) CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6e:B (ILE35) to (TRP95) CD1A BINARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE | CD1A, IMMUNE COMPLEX, LIPID ANTIGEN, TCR, IMMUNE SYSTEM
4x7t:H (PRO157) to (PRO221) STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2 | ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM
4x7t:A (PRO157) to (PRO221) STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2 | ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM
4x80:H (PRO160) to (LYS220) CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5 | MONOCLONAL, IMMUNE SYSTEM
2bsr:B (ASP34) to (LYS94) CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | IMMUNE SYSTEM/PEPTIDE, MHC, HLA-B27, HUMAN EBV, HIV, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, NUCLEAR PROTEIN, COMPLEX (ANTIGEN/PEPTIDE)
2bss:B (ILE35) to (LYS94) CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), MHC HLA-B27, HUMAN EBV HIV, COMPLEX ANTIGEN PEPTIDE
2bst:B (ILE35) to (LYS94) CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | IMMUNE SYSTEM-PEPTIDE COMPLEX, MHC, HLA-B27, HUMAN EBV, HIV, FLU, GLYCOPROTEIN, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, COMPLEX (ANTIGEN/PEPTIDE), VIRAL NUCLEOPROTEIN
4x98:A (ILE377) to (LEU443) IMMUNOGLOBULIN FC HETERODIMER VARIANT | BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM
1ob1:B (VAL150) to (PRO212) CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19 | IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT
1ob1:E (VAL150) to (PRO212) CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19 | IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT
4hs6:B (PRO149) to (PRO213) HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362 | IMMUNE SYSTEM
1bx2:B (SER126) to (ARG189) CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN | HLA-DR2, MYELIN BASIC PROTEIN, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM
1bx2:D (VAL117) to (PHE180) CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN | HLA-DR2, MYELIN BASIC PROTEIN, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM
1bx2:E (SER126) to (ARG189) CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN | HLA-DR2, MYELIN BASIC PROTEIN, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM
4xak:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD | MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM
4xaw:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA) | HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM
4xbg:E (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbg:G (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbp:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
4xbp:C (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
2bvo:B (ASP34) to (LYS94) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, SIGNAL, TRANSMEMBRANE, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID
2bvp:B (ASP34) to (HIS84) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP, HIV-1, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, IMMUNE RESPONSE
4hux:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H2DB-H155A-NP | VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM
4hux:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2DB-H155A-NP | VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM
3fct:B (PRO150) to (PRO214) MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN | METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
4hw6:C (VAL82) to (CYS131) CRYSTAL STRUCTURE OF AN AUXILIARY NUTRIENT BINDING PROTEIN (BACOVA_00264) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.70 A RESOLUTION | PUTATIVE CARBOHYDRATE BINDNING TWO DOMAINS PROTEIN, IPT/TIG DOMAIN (PF01833), 6-BETA-PROPELLER, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION
3scm:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE | TERNARY COMPLEX, IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM
3scm:D (HIS157) to (TRP243) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE | TERNARY COMPLEX, IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM
4hwe:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT | FAB, FNIII, IMMUNE SYSTEM
1c16:B (ILE35) to (LYS94) CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 | NON-CLASSICAL MHC-LIKE, MAJOR HISTOCOMPATIBILITY, BETA2- MICROGLOBULIN, IMMUNE SYSTEM
1c16:D (ILE35) to (LYS94) CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 | NON-CLASSICAL MHC-LIKE, MAJOR HISTOCOMPATIBILITY, BETA2- MICROGLOBULIN, IMMUNE SYSTEM
1c16:F (ILE35) to (LYS94) CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 | NON-CLASSICAL MHC-LIKE, MAJOR HISTOCOMPATIBILITY, BETA2- MICROGLOBULIN, IMMUNE SYSTEM
1c16:H (ILE35) to (LYS94) CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 | NON-CLASSICAL MHC-LIKE, MAJOR HISTOCOMPATIBILITY, BETA2- MICROGLOBULIN, IMMUNE SYSTEM
4hwz:B (ILE35) to (LYS94) STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE | HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM
4hx1:B (ASP35) to (LYS95) STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE | HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM
4hxb:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF 6B9 FAB | ANTIBODY, FAB, COMPLEMENTARITY DETERMINING REGIONS, CARBOHYDRATE- BINDING, IMMUNE SYSTEM
4xce:A (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xcn:A (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:G (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
3ffc:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR | TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ffc:G (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR | TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3sdx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, EXTRACELLULAR, IMMUNE SYSTEM
3sdx:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, EXTRACELLULAR, IMMUNE SYSTEM
3se8:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC03, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1oga:B (ASP34) to (LYS94) A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR
1oga:E (HIS154) to (ASP244) A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR
3sep:A (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) | DYNAMIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, BETA- GALACTOSIDASE, GLYCOSIDASE, HYDROLASE
4i0p:D (ASP126) to (GLN191) HLA-DO IN COMPLEX WITH HLA-DM | HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM
4i0p:H (ASP126) to (GLN191) HLA-DO IN COMPLEX WITH HLA-DM | HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM
2po6:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN | CD1D-LIPID ANTIGEN NKT15 COMPLEX, LIPID BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
2po6:E (PRO215) to (TRP277) CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN | CD1D-LIPID ANTIGEN NKT15 COMPLEX, LIPID BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
2po6:F (ASP34) to (LYS94) CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN | CD1D-LIPID ANTIGEN NKT15 COMPLEX, LIPID BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
2po6:H (HIS157) to (ALA246) CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN | CD1D-LIPID ANTIGEN NKT15 COMPLEX, LIPID BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
4i18:H (PRO164) to (PRO228) CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT | IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN
4i18:A (PRO164) to (PRO228) CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT | IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN
4xgz:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:C (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:E (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:G (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:J (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:M (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:O (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:Q (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:S (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:W (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
2c1p:B (PRO149) to (PRO212) FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE | FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENANTIOSELECTIVE ANTIBODY, IMMUNOGLOBULIN DOMAIN
4xhj:H (PRO156) to (GLU219) GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES. | COMPLEX, NEUTRALIZATION EPITOPES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ce6:B (ILE35) to (LYS94) MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE | MHC CLASS I, ANTIGEN PRESENTATION, VIRAL PEPTIDE, COMPLEX
3sjv:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR | T CELL, IMMUNE SYSTEM
3sjv:G (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR | T CELL, IMMUNE SYSTEM
3sjv:O (HIS165) to (GLY252) CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR | T CELL, IMMUNE SYSTEM
1om3:H (PRO151) to (PRO227) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
1om3:K (PRO151) to (PRO227) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
4i4w:B (ASP34) to (LYS94) PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT | MHC I FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, IMMUNE SYSTEM
3skj:H (PRO146) to (CYS213) STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY | FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM
1cfs:B (PRO148) to (PRO211) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE | POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1
3fn0:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41 | Z13E1, Z13, HIV, ENV, GP41, IMMUNE SYSTEM
2pw2:B (PRO150) to (PRO214) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL | HIV-1, GP41, 2F5, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
1onq:B (ILE35) to (ARG97) CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE | PROTEIN-GLYCOLIPID COMPLEX, BETA SHEET PLATFORM,, IMMUNE SYSTEM
1onq:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE | PROTEIN-GLYCOLIPID COMPLEX, BETA SHEET PLATFORM,, IMMUNE SYSTEM
3fo0:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3fo1:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3fo2:B (PRO157) to (PRO221) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1op5:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 | DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1op5:M (PRO151) to (PRO227) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 | DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
4i77:H (PRO149) to (SER213) LEBRIKIZUMAB FAB BOUND TO IL-13 | IMMUNOGLOBULIN, IMMUNE SYSTEM RECOGNITION, IMMUNE SYSTEM-CYTOKINE COMPLEX
1ors:B (PRO154) to (PRO217) X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB | POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, VOLTAGE SENSOR, KVAP, FAB COMPLEX, MEMBRANE PROTEIN
3fqn:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqt:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqu:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqw:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqx:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
1ots:E (PRO157) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX | CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN
3ft3:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2 | HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM
3ft4:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2 | HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM
1cqk:A (ILE38) to (HIS104) CRYSTAL STRUCTURE OF THE CH3 DOMAIN FROM THE MAK33 ANTIBODY | CONSTANT DOMAIN, C1-SUBSET, IMMUNOGLOBULIN, IMMUNE SYSTEM
3sqo:H (PRO153) to (GLU216) PCSK9 J16 FAB COMPLEX | CHOLESTEROL REGULATION, LDLR, HYDROLASE-IMMUNE SYSTEM COMPLEX
2q3z:A (CYS620) to (ASN681) TRANSGLUTAMINASE 2 UNDERGOES LARGE CONFORMATIONAL CHANGE UPON ACTIVATION | TRANSGLUTAMINASE 2, TISSUE TRANSGLUTAMINASE, TG2, TRANSFERASE
2c7u:B (ASP34) to (LYS94) CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. | GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS
2c7u:E (ASP34) to (LYS94) CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. | GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS
2c9i:H (CYS138) to (SER217) STRUCTURE OF THE FLUORESCENT PROTEIN ASFP499 FROM ANEMONIA SULCATA | FLUORESCENT PROTEIN, BETA-BARREL, BIOLUMINESCENCE, LUMINESCENCE, LUMINESCENT PROTEIN
4xml:H (VAL150) to (PRO213) CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 | HIV-1 GP120, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2q7a:A (ASN99) to (ALA163) CRYSTAL STRUCTURE OF THE CELL SURFACE HEME TRANSFER PROTEIN SHP | BETA SANDWICH, HEME BINDING PROTEIN
4xmn:H (PRO186) to (PRO250) STRUCTURE OF THE YEAST COAT NUCLEOPORIN COMPLEX, SPACE GROUP P212121 | STRUCTURAL PROTEIN, PROTEIN TRANSPORT
2q7y:B (ILE35) to (TYR94) STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D | ANTIGEN PRESENTING MOLECULE, MHC FOLD, NKT CELLS, IMMUNE SYSTEM
2q7y:D (ILE35) to (TYR94) STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D | ANTIGEN PRESENTING MOLECULE, MHC FOLD, NKT CELLS, IMMUNE SYSTEM
3fzu:C (PRO154) to (PRO218) IGG1 FAB CHARACTERIZED BY H/D EXCHANGE | IGG1 FAB, IMMUNE SYSTEM
2cdf:B (HIS155) to (ALA244) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E) | CELL RECEPTOR, CD1D, ALPHA-GALACTOSYLCERAMIDE, NON-CANONICAL TCR, TCR, T CELL RECEPTOR, MHC CLASS I, NATURAL KILLER T CELL, TCR 5E
4ihb:D (ASP18) to (LYS85) X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN | BETA SANDWICH, TYPE II C2 DOMAIN, MUSCULAR DYSTROPHY, MEMBRANE PROTEIN, MEMBRANE REPAIR, PLASMA MEMBRANE
4xnx:H (PRO155) to (PRO218) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH REBOXETINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX
4xny:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4iib:A (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iib:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iic:A (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iic:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iid:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4xp9:H (PRO155) to (LYS215) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT D-AMPHETAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, MEMBRANE PROTEIN, PROTEIN TRANSPORT, TRANSPORT PROTEIN-INHIBITOR COMPLEX
4iie:A (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2) | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iie:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2) | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iif:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
1d6v:H (PRO149) to (PRO213) CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION | IMMUNE SYSTEM
4iig:A (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4iig:B (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
4ij2:E (LYS397) to (PHE458) HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS | NEAT, HEME/HEMOGLOBIN BINDING, HEMOGLOBIN, CELL WALL ASSOCIATED, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX
4ij2:F (LYS397) to (PHE458) HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS | NEAT, HEME/HEMOGLOBIN BINDING, HEMOGLOBIN, CELL WALL ASSOCIATED, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX
4ij2:G (LYS397) to (PHE458) HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS | NEAT, HEME/HEMOGLOBIN BINDING, HEMOGLOBIN, CELL WALL ASSOCIATED, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX
4ij2:H (LYS397) to (PHE458) HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS | NEAT, HEME/HEMOGLOBIN BINDING, HEMOGLOBIN, CELL WALL ASSOCIATED, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX
1d9k:H (LYS126) to (ARG189) CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA | T-CELL RECEPTOR, MHC CLASS II, D10, I-AK, IMMUNE SYSTEM
2chz:A (LEU379) to (LEU467) A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93 | PHOSPHOINOSITIDE, KINASE, LIPID, INHIBITOR, 3-KINASE, SIGNALING, PHENYLTHIAZOLE, QUINAZOLINONE, TRANSFERASE
2cii:B (ILE35) to (LYS94) THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY- INTERMEDIATE | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), MHC CLASS I, PEPTIDE BINDING, SENDAI VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE
2cik:B (ILE35) to (HIS84) INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. | IMMUNE SYSTEM/PEPTIDE, ANTIGEN/PEPTIDE COMPLEX, MAJOR HISTOCOMPATIBILITY ANTIGEN, HUMAN, MHC, HLA, HLA-B3501, EBV, ALLO-LIGAND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID
3t08:C (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX | DYNAMPIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
3g5z:B (SER152) to (LYS212) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
3t09:B (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX | DYNAMPIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
1de4:B (ILE35) to (TRP95) HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR | HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX
1de4:E (ILE35) to (TRP95) HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR | HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX
1de4:H (ILE35) to (TRP95) HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR | HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX
4xs0:C (LYS397) to (PHE458) HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH(F365Y/A369F/Y642A) FROM STAPHYLOCOCCUS AUREUS | NEAT, HEME/HEMOGLOBIN BINDING, HEMOGLOBIN, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX, OXYGEN TRANSPORT, METAL TRANSPORT
4imk:A (PRO165) to (PRO229) UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2 | ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
4imk:B (PRO165) to (PRO229) UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2 | ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
2clr:B (ILE35) to (LYS94) THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE | HISTOCOMPATIBILITY ANTIGEN
2clr:E (ILE35) to (LYS94) THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE | HISTOCOMPATIBILITY ANTIGEN
2clv:B (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE | IMMUNE RESPONSE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, TRANSMEMBRANE, ALLOREACTIVITY, MHC I, H-2KBM8, MEMBRANE, CLASS I MHC, POLYMORPHISM
2clz:B (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE | IMMUNE RESPONSE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, TRANSMEMBRANE, ALLOREACTIVITY, MHC I, H-2KBM8, MEMBRANE, CLASS I MHC, POLYMORPHISM
2clz:P (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE | IMMUNE RESPONSE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, TRANSMEMBRANE, ALLOREACTIVITY, MHC I, H-2KBM8, MEMBRANE, CLASS I MHC, POLYMORPHISM
3t0e:B (SER155) to (ARG218) CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR, PEPTIDE-MHC AND CD4 | CD4, T CELL RECEPTOR, TCR, HLA CLASS II, MHC, AUTOIMMUNITY, T CELL ACTIVATION, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, MEMBRANE
1pfc:A (ASP376) to (ARG443) MOLECULAR-REPLACEMENT STRUCTURE OF GUINEA PIG IGG1 P*FC(PRIME) REFINED AT 3.1 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
4iof:E (VAL166) to (LYS226) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) | HYDROLASE, ZINC METALLOPROTEASE
4ioi:B (PRO156) to (PRO220) MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER IMMUNOTHERAPY
3t1f:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3t2p:B (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG | DYNAMIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
3t2p:C (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG | DYNAMIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
3gbl:A (ILE35) to (VAL92) CRYSTAL STRUCTURE OF GRASS CARP BETA2-MICROGLOBULIN | BETA2-MICROGLOBULIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM
3gbm:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
3t2q:B (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE | DYNAMIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
3t2q:D (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE | DYNAMIC LOOP CONFORMATION, SER-796, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, GLYCOSIDASE, HYDROLASE
4xtr:C (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4irs:B (HIS34) to (TYR94) STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4irz:H (PRO159) to (GLU222) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB | ROLLING AND FIRM ADHESION, MADCAM, IMMUNE SYSTEM
4is6:B (SER126) to (ARG189) CRYSTAL STRUCTURE OF HLA-DR4 BOUND TO GP100 PEPTIDE | MHC CLASS II, HLA-DR4, GP100, IMMUNE SYSTEM
3t3m:H (PRO155) to (LYS215) A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS | INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET
4xwo:E (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:I (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:K (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:O (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:U (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
2qql:H (PRO149) to (PRO213) NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
2qqn:H (PRO149) to (PRO213) NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, HEPARAN SULFATE, MEMBRANE, NEUROGENESIS, PROTEOGLYCAN, SECRETED, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
2qr0:B (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:F (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:H (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:L (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:N (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:R (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:T (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:X (PRO149) to (PRO213) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
4xxc:C (ILE35) to (LYS94) HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE, DELEIKAY | EBV, HLA, TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
1dqj:B (PRO149) to (LYS220) CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIBODY, PROTEIN-PROTEIN COMPLEX, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM/HYDROLASE COMPLEX
2qri:A (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB WT, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE. | MHC-I, OVA, SINGLE CHAIN MHC-I, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
2qrs:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84A, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE. | MHC-I, SINGLE CHAIN, OVALBUMIN, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
2qrt:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C, BETA- 2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE. | MHC-I, OVA, SINGLE CHAIN MHC-I, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
2qsc:H (PRO151) to (GLU226) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNOGLOBULIN FOLD, AIDS, APOPTOSIS, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
1duy:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1duy:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1duz:B (ILE35) to (LYS94) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1duz:E (ILE35) to (LYS94) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3giv:B (ILE35) to (LYS94) ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE | HIV, MHC, ESCAPE, ANTIGEN, IMMUNE RECOGNITION, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED', IMMUNE SYSTEM
3giv:E (ILE35) to (LYS94) ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE | HIV, MHC, ESCAPE, ANTIGEN, IMMUNE RECOGNITION, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED', IMMUNE SYSTEM
4xzu:A (PRO152) to (PRO215) CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY | IMMUNOGLOBULIN, BLOOD COAGULATION, ANTIBODY, DISCOIDIN, IMMUNE SYSTEM
3t8x:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER | ENDOGENOUS SPACER LIGAND, MYCOBACTERIAL DIACYLSULFOGLYCOLIPID, MHC, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN/MHC I, ANTIGEN PRESENTATION, GLYCOLIPID ANTIGEN BINDING, GLYCOSYLATION, CELL MEMBRANE
3t8x:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER | ENDOGENOUS SPACER LIGAND, MYCOBACTERIAL DIACYLSULFOGLYCOLIPID, MHC, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN/MHC I, ANTIGEN PRESENTATION, GLYCOLIPID ANTIGEN BINDING, GLYCOSYLATION, CELL MEMBRANE
4y16:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4y16:D (HIS151) to (ALA240) CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4y1a:B (ILE127) to (ALA190) IMMUNE COMPLEX | TCR MHC, IMMUNE SYSTEM
2d2o:A (VAL35) to (GLY97) STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT | BETA/ALPHA BARREL, HYDROLASE
2d31:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER | MHC CLASS I, IMMUNE SYSTEM/CELL CYCLE COMPLEX
3gmm:B (ILE35) to (TRP95) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmn:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmp:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25 | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmq:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmr:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
4y2d:F (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
1e27:B (ILE35) to (LYS94) NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) | IMMUNE SYSTEM, HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1e28:B (ILE35) to (LYS94) NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI) | HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
4j1u:D (PRO153) to (PRO217) CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT | ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM
4y4k:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
2r0l:H (PRO149) to (PRO213) SHORT FORM HGFA WITH INHIBITORY FAB75 | SERINE PROTEASE, ANTIBODY, ALLOSTERIC INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM
3tby:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
1e4x:I (PRO146) to (PRO209) CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT | IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION
2r2e:B (PRO147) to (PRO210) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
3tcl:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
1py4:A (ILE35) to (HIS84) BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS | AMYLOID, DIALYSIS RELATED AMYLOIDOSIS, C-TYPE IMMUNOGLOBULIN, PROTEIN MUTANT, SIGNALING PROTEIN
1py4:B (ASP34) to (LYS94) BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS | AMYLOID, DIALYSIS RELATED AMYLOIDOSIS, C-TYPE IMMUNOGLOBULIN, PROTEIN MUTANT, SIGNALING PROTEIN
1py4:C (ASP34) to (LYS94) BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS | AMYLOID, DIALYSIS RELATED AMYLOIDOSIS, C-TYPE IMMUNOGLOBULIN, PROTEIN MUTANT, SIGNALING PROTEIN
1py4:D (ILE35) to (TRP95) BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS | AMYLOID, DIALYSIS RELATED AMYLOIDOSIS, C-TYPE IMMUNOGLOBULIN, PROTEIN MUTANT, SIGNALING PROTEIN
3grw:H (PRO149) to (PRO213) FGFR3 IN COMPLEX WITH A FAB | FGFR3, FAB, PROTEIN-PROTEIN COMPLEX, RECEPTOR TYROSINE KINASE, ATP- BINDING, IMMUNOGLOBULIN DOMAIN, KINASE, MEMBRANE, NUCLEOTIDE- BINDING, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4j4p:C (PRO182) to (PRO246) THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS | IG LIKE DOMAIN, IMMUNE SYSTEM
2r56:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
3gsr:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gsu:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gsv:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gsw:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gsx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1e7v:A (ASP378) to (LEU467) STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE | TRANSFERASE, SECONDARY MESSENGER GENERATION PI3K, PI 3K, LY294002
3tid:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE LCMV DERIVED PEPTIDE GP34 IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB | ANTIGEN PRESENTATION, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM
1eap:B (SER160) to (LYS219) CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE | CATALYTIC ANTIBODY
1q72:H (PRO151) to (PRO227) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
4jdt:H (PRO153) to (GLU216) CRYSTAL STRUCTURE OF CHIMERIC GERM-LINE PRECURSOR OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV-1 | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4jdv:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB | IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM
3tlr:A (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE TETRAMERIC BETA-2 MICROGLOBULIN DIMC20 MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tlr:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE TETRAMERIC BETA-2 MICROGLOBULIN DIMC20 MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
1eey:B (ILE35) to (LYS94) CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) | MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1eey:E (ILE35) to (LYS94) CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) | MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1eez:B (ASP34) to (LYS94) CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L) | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1eez:E (ASP34) to (LYS94) CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L) | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1q94:B (ILE35) to (LYS94) STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE | IMMUNE SYSTEM
3tm6:A (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:C (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:E (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:F (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:G (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
3tm6:H (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BETA-2 MICROGLOBULIN DIMC50 DISULPHIDE-LINKED HOMODIMER MUTANT | IMMUNOGLOBULIN-LIKE FOLD, MHC CLASS I, LIGHT CHAIN, IMMUNE SYSTEM
1q9l:B (PRO147) to (PRO210) S25-2 FAB UNLIGANDED 2 | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q9w:C (ALA34) to (ALA108) S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CABOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, PROTEIN-CARBOHYDRATE COMPLEX, IMMUNE SYSTEM
4jfd:B (ILE35) to (LYS94) PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR | HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY, IMMUNOGLOBULIN
4jfe:B (ILE35) to (LYS94) PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR | HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jff:B (ILE35) to (LYS94) PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR | HLA, TCR, MELANOMA MOTIF, IMMUNE SYSTEM, HIGH AFFINITY
1efx:B (ASP34) to (LYS94) STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 | MHC, HLA, CLASS I, KIR, NK CELL RECEPTOR, IMMUNOGLOBULIN FOLD, RECEPTOR/MHC COMPLEX, IMMUNE SYSTEM
4jfo:B (ILE35) to (LYS94) A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfo:E (ILE35) to (LYS94) A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfq:E (ILE35) to (LYS94) A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
3tnn:F (ALA144) to (ALA208) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3to2:B (ASP34) to (LYS94) STRUCTURE OF HLA-A*0201 COMPLEXED WITH PEPTIDE MD3-C9 DERIVED FROM A CLUSTERING REGION OF RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPE FROM SARS-COV M PROTEIN | PRESENTATION, HLA, CTL EPITOPE, IMMUNE SYSTEM
4jfx:H (PRO149) to (PRO213) STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4jfy:B (PRO149) to (PRO213) APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4jfy:H (PRO149) to (PRO213) APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4jg0:H (PRO149) to (PRO213) STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4jg1:H (PRO149) to (PRO213) STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4yaq:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT | ANTIBODY, HIV, IMMUNE SYSTEM
4jha:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25 | IMMUNOGLOBULIN, IG, IMMUNE SYSTEM
4ybl:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32 | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4jhw:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25 | IMMUNOGLOBULIN; TYPE I FUSION PROTEIN, MEMBRANE FUSION, IMMUNE SYSTEM
1qbl:H (PRO153) to (PRO216) FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY
1qfu:H (PRO149) to (PRO212) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMMUNOGLOBULIN), HEMAGGLUTININ, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ydl:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ydl:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
2dwx:B (VAL559) to (GLY625) CO-CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE WITH THE WNSF MOTIF | IG FOLD, ADAPTIN, PROTEIN TRANSPORT
4ydv:H (PRO149) to (PRO213) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4ydv:B (PRO149) to (PRO213) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4ye4:H (PRO163) to (PRO227) CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120 | HIV1, ANTIBODY, GP120, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3tt3:H (PRO155) to (PRO218) CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB | LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN
2rfx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF | ALPHA BETA SANDWICH-IMMUNOLOGLOBULIN LIKE, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1emt:H (PRO152) to (PRO215) FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY | ANTI-FULLERENE ANTIBODY, NANOTUBES, IMMUNE SYSTEM
1eo8:H (PRO149) to (PRO212) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ-IMMMUNOGLOBULIN), HEMAGGLUTININ, IMMUNOGLOBULIN, VIRAL PROTEIN, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
2rh7:A (VAL141) to (ALA220) CRYSTAL STRUCTURES OF THE LUCIFERASE AND GREEN FLUORESCENT PROTEIN FROM RENILLA RENIFORMIS | FLUORESCENT PROTEIN
2rh7:B (VAL141) to (ALA221) CRYSTAL STRUCTURES OF THE LUCIFERASE AND GREEN FLUORESCENT PROTEIN FROM RENILLA RENIFORMIS | FLUORESCENT PROTEIN
2rh7:C (VAL141) to (ALA220) CRYSTAL STRUCTURES OF THE LUCIFERASE AND GREEN FLUORESCENT PROTEIN FROM RENILLA RENIFORMIS | FLUORESCENT PROTEIN
4jkp:H (PRO153) to (PRO217) RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES | IGG, ANTIBODY, GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1qlf:B (ILE35) to (LYS94) MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G | IMMUNE SYSTEM/PEPTIDE, MURINE CLASS I MHC/PEPTIDE COMPLEX, MHC, GLYCOPEPTIDE, ANTIGEN, HISTOCOMPATIBILITY, IMMUNOLOGY
4jlr:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB | ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM
4jm2:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jm4:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF PGT 135 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1evu:A (ASN662) to (ARG727) HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, TRANSFERASE
1evu:B (VAL663) to (ARG727) HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, TRANSFERASE
4jn2:B (PRO159) to (PRO223) AN ANTIDOTE FOR DABIGATRAN | IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX
4jo4:H (PRO149) to (PRO210) CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB | IG, ANTIBODY, IMMUNE SYSTEM
1ex0:A (ASN662) to (ARG727) HUMAN FACTOR XIII, MUTANT W279F ZYMOGEN | TRANSGLUTAMINASE, BLOOD COAGULATION, MUTANT, W279F, OXYANION, TRANSFERASE
1ex0:B (VAL663) to (ARG727) HUMAN FACTOR XIII, MUTANT W279F ZYMOGEN | TRANSGLUTAMINASE, BLOOD COAGULATION, MUTANT, W279F, OXYANION, TRANSFERASE
2seb:B (SER126) to (ALA190) X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | COMPLEX (MHC CLASS II-SUPERANTIGEN), COMPLEX (MHC CLASS II- SUPERANTIGEN) COMPLEX
4jpi:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4jpk:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | HIV-1 GP120, CD4 BINDING, VRC01-LIKE BROADLY NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4ygv:A (PRO155) to (PRO219) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4ygv:F (PRO155) to (PRO219) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4jqi:H (PRO159) to (PRO223) STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE | ARRESTIN, GPCR, G-PROTEIN COUPLED RECEPTOR, SIGNALING, SIGNALING PROTEIN
4jqv:C (ASP34) to (LYS94) HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180) | IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM
4jqx:C (ASP34) to (LYS94) HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180) | IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM
4yhi:A (PRO155) to (PRO219) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhi:H (PRO155) to (PRO219) REVERSAL AGENT FOR DABIGATRAN | ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM
4yhn:F (PRO155) to (PRO219) DABIGATRAN REVERSAL AGENT | ANTIBODIES, IMMUNE SYSTEM
4yhp:A (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhp:C (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhp:E (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhp:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhy:B (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS | ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM
4yhy:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS | ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM
4yhz:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF 304M3-B FAB IN COMPLEX WITH H3K4ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K4ME3, IMMUNE SYSTEM
1f13:A (VAL663) to (ARG727) RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII | COAGULATION, TRANSGLUTAMINASE, TRANSFERASE, ACYLTRANSFERASE, BLOOD COAGULATION, COAGULATION FACTOR
1f13:B (VAL663) to (ASP722) RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII | COAGULATION, TRANSGLUTAMINASE, TRANSFERASE, ACYLTRANSFERASE, BLOOD COAGULATION, COAGULATION FACTOR
4jry:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
1qrk:A (ASN662) to (ARG727) HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, STRONTIUM, TRANSFERASE
1qrk:B (VAL663) to (ARG727) HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, STRONTIUM, TRANSFERASE
1qse:B (ILE35) to (LYS94) STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R | HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM
4yk4:Z (PRO161) to (PRO225) HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006 | INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1qsf:B (ASP34) to (LYS94) STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A | HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM
3tzv:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE | IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM
3u0p:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE | ANTIGEN PRESENTATION, NATURA KILLER T CELL RECEPTOR, CELL SURFACE, IMMUNE SYSTEM
3u0t:D (PRO148) to (ARG213) FAB-ANTIBODY COMPLEX | ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM
3u0t:B (PRO148) to (ARG213) FAB-ANTIBODY COMPLEX | ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM
3u1s:H (PRO154) to (PRO218) CRYSTAL STRUCTURE OF HUMAN FAB PGT145, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | IGG, BROADLY NEUTRALIZING ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
1qvo:E (ASP34) to (LYS94) STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE | IMMUNE SYSTEM
3h9h:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h9h:E (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3u36:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:B (THR145) to (PRO208) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:D (THR145) to (PRO208) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3u36:F (THR145) to (PRO208) CRYSTAL STRUCTURE OF PG9 FAB | IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM
3h9s:B (ILE35) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:B (ILE35) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:E (ILE35) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:K (ILE35) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:Q (ILE35) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:T (PRO155) to (PRO219) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1f8t:H (PRO151) to (PRO227) FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL, IMMUNE SYSTEM
4jvf:B (GLU72) to (VAL150) THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX WITH THE INHIBITOR (S)-5 | IMMUNOGLOBULIN-LIKE BETA-SANDWICH, GDI-LIKE SOLUBILIZING FACTOR, PRENYL BINDING, PROTEIN BINDING-INHIBITOR COMPLEX
2uwe:B (ASP34) to (LYS94) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION | HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE MUTATION
2uwe:I (ASP34) to (LYS94) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION | HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE MUTATION
3hc0:A (PRO152) to (PRO216) BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR | IGG1 FAB, BHA10, IMMUNE SYSTEM
1r24:B (VAL159) to (LEU215) FAB FROM MURINE IGG3 KAPPA | PRELIMINARY, IMMUNE SYSTEM
1fc1:B (ASP376) to (LEU443) CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
2eh8:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE | CRYSTAL STRUCTURE, HEPATITIS B VIRUS, HUMANIZED ANTIBODY, MONOCLONAL ANTIBODY, NEUTRALIZATION, PRES1, IMMUNE SYSTEM
4jy6:A (THR149) to (ALA211) CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM
3he6:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR | MOUSE CD1D, MOUSE NKT T-CELL RECEPTORS, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, IMMUNE SYSTEM
1fe8:J (PRO151) to (PRO214) CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING | COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM
4jzn:A (PRO155) to (PRO219) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzn:C (PRO155) to (PRO219) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzn:I (PRO155) to (PRO219) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:A (PRO155) to (PRO219) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jzo:G (PRO155) to (PRO219) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1r3h:B (ASP2034) to (LYS2094) CRYSTAL STRUCTURE OF T10 | CLASS IB MHC, GAMMADELTA T CELL LIGAND, IMMUNE SYSTEM
1r3h:H (ILE8035) to (LYS8094) CRYSTAL STRUCTURE OF T10 | CLASS IB MHC, GAMMADELTA T CELL LIGAND, IMMUNE SYSTEM
1fg9:D (ARG153) to (GLU212) 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER | CYTOKINE-RECEPTOR COMPLEX, FIBRONECTIN TYPE-III, IMMUNE SYSTEM
1fg9:E (ARG153) to (GLU212) 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER | CYTOKINE-RECEPTOR COMPLEX, FIBRONECTIN TYPE-III, IMMUNE SYSTEM
1r5i:B (SER126) to (ARG189) CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX | SUPERANTIGEN, MHC, MAM, COMPLEX, IMMUNE SYSTEM
1r5i:F (SER126) to (ARG189) CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX | SUPERANTIGEN, MHC, MAM, COMPLEX, IMMUNE SYSTEM
1r5v:B (ASN153) to (TRP215) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
1r5v:D (ASN153) to (TRP215) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
1r5w:A (ASN118) to (GLU179) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
1r5w:B (ASN153) to (TRP215) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
1r5w:C (ASN118) to (GLU179) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
1r5w:D (ASN153) to (TRP215) EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION | TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN
4ypg:H (PRO152) to (PRO216) STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY | THERAPEUTIC MAB, IFN-ALPHA2A
2v2x:B (ILE35) to (LYS94) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. | IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID
2v2x:E (ILE35) to (LYS94) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. | IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID
3hi6:X (PRO156) to (SER220) CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57 | INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX
2esv:A (GLU212) to (TRP274) STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX | T CELL RECEPTOR, TCR, HLA-E, CMV, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2esv:B (ILE35) to (LYS94) STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX | T CELL RECEPTOR, TCR, HLA-E, CMV, PMHC/TCR COMPLEX, IMMUNE SYSTEM
4k3j:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA | ANTIBODY, GLYCOSYLATION, TRANSFERASE-IMMUNE SYSTEM-GROWTH FACTOR COMPLEX
1fne:B (ASN126) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM
1fne:D (ILE127) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM
1fng:B (ASN126) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM
1fng:D (ASN126) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM
1fns:H (PRO372) to (PRO435) CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4 | VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND-IMMUNOGLOBULIN), BLOOD COAGULATION TYPE 2B VON WILLEBRAND DISEASE, IMMUNE SYSTEM
1fo0:L (HIS34) to (ARG97) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, IMMUNE SYSTEM
3hkf:A (ASP379) to (SER445) MURINE UNGLYCOSYLATED IGG FC FRAGMENT | ANTIBODY, GLYCOSYLATION, STABILITY, IMMUNE SYSTEM
1fpt:H (PRO151) to (PRO227) THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE | COMPLEX (ANTIBODY-PV-1 FRAGMENT), COMPLEX (ANTIBODY-PV-1 FRAGMENT) COMPLEX
2v7n:D (PRO185) to (PRO249) UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4 | BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM
2v7n:F (PRO185) to (PRO249) UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4 | BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM
4k7f:B (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201 | HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN
4k7f:E (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201 | HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN
1rfd:H (PRO151) to (PRO227) ANTI-COCAINE ANTIBODY M82G2 | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
4k7p:Y (PRO149) to (PRO213) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
4k7p:H (PRO149) to (ASP211) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
1ft0:B (LYS127) to (LYS200) CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI K113A MUTANT | IMMUNOGLOBULIN FOLD, BETA SANDWICH MOTIF, ISOPRENYL-BINDING DOMAIN, GDP-DISSOCIATION INHIBITOR OF RHO GTPASES, SIGNALING PROTEIN INHIBITOR
3ujt:H (PRO149) to (PRO212) STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS | IMMUNOGLOBULIN, IMMUNE SYSTEM, O-ANTIGEN
1riv:H (PRO151) to (PRO227) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
4k9e:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D | RECEPTOR TYROSINE KINASE (RTK), IGG, FAB, IMMUNE SYSTEM
1rjz:B (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1rjz:E (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1fv1:B (SER126) to (ARG189) STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES | MHC CLASS II DR2A, IMMUNE SYSTEM
4ywg:H (PRO149) to (ASP208) CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2 | HIV-1 GP120, THE V1V2 REGION, ANTIBODY, COMPLEX STRUCTURE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ywg:I (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2 | HIV-1 GP120, THE V1V2 REGION, ANTIBODY, COMPLEX STRUCTURE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3uls:A (THR146) to (ALA208) CRYSTAL STRUCTURE OF FAB12 | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulu:H (PRO157) to (HIS220) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
4kaq:H (PRO157) to (PRO221) STRUCTURE OF RITUXIMAB FAB | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2f53:B (ILE35) to (ARG97) DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2f54:B (ASP34) to (LYS94) DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM
2f54:G (ILE35) to (ARG97) DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM
1rmf:H (VAL156) to (ILE216) STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
2vc2:H (PRO155) to (PRO218) RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758 | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE,
2f74:B (ILE35) to (ARG97) MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM
2f74:E (ASP34) to (LYS94) MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM
3hmw:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF USTEKINUMAB FAB | USTEKINUMAB, CNTO1275, IL-12, IL-23, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3hmx:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX | USTEKINUMAB, CNTO1275, IL-12, IL-23, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, SECRETED, GROWTH FACTOR, CYTOKINE-MMUNE SYSTEM COMPLEX, CYTOKINE-IMMUNE SYSTEM COMPLEX
1rsy:A (GLY175) to (PRO246) STRUCTURE OF THE FIRST C2-DOMAIN OF SYNAPTOTAGMIN I: A NOVEL CA2+(SLASH)PHOSPHOLIPID BINDING FOLD | CALCIUM/PHOSPHOLIPID BINDING PROTEIN
2fb4:L (ALA145) to (PRO210) DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN) | IMMUNOGLOBULIN
2fbj:H (THR154) to (ASP215) REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
1ru9:H (PRO151) to (PRO227) CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE. | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
1rua:H (VAL152) to (PRO227) CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1. | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
1ruk:H (PRO151) to (PRO227) CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1 | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
1rul:H (PRO151) to (PRO227) CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1. | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
1rum:H (PRO151) to (PRO227) CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1. | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
1ruq:H (PRO151) to (PRO227) CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE. | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM
2fec:I (PRO157) to (PRO220) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2vdk:H (PRO155) to (PRO218) RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, PHOSPHORYLATION,
2ve6:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
2ve6:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
2ve6:H (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
2ve6:K (HIS34) to (TRP95) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
4kht:H (PRO156) to (PRO220) TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066 | GP41 FAB IMMUNE SYSTEM, IMMUNE SYSTEM
4kht:L (THR147) to (ALA209) TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066 | GP41 FAB IMMUNE SYSTEM, IMMUNE SYSTEM
1rz8:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:C (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:D (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:F (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:H (PRO149) to (LYS209) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:L (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:N (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
3hpj:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE | WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hpj:E (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE | WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4z5r:K (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:M (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:W (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:Q (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:U (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:B (PRO149) to (PRO213) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
2fik:B (HIS34) to (TYR94) STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D | NKT CELLS, CD1D, MHC-FOLD, IMMUNE SYSTEM, BACTERIAL ANTIGEN, TCR
4kjq:C (PRO157) to (HIS207) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, FLUORIDE, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kjq:E (PRO157) to (PRO220) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, FLUORIDE, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kjw:C (PRO157) to (PRO220) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN, MEMBRANE PROTEIN
2fjf:B (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:D (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:F (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:I (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:K (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:N (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:P (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:R (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:T (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:V (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:X (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjg:B (PRO156) to (PRO220) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | PROTEIN FAB COMPLEX, FAB, VEGF, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
2fjh:H (PRO157) to (PRO221) STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
2fjh:B (PRO157) to (PRO221) STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
4kk5:C (PRO157) to (PRO220) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, FLUORIDE, BROMIDE, TRANSPORT PROTEIN
1gaf:H (PRO150) to (PRO214) 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID | ESTER HYDROLYSIS, ESTEROLYTIC, FAB, CATALYTIC ANTIBODY
4kk9:C (PRO157) to (PRO220) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
3uts:B (ILE35) to (LYS94) 1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM
3utt:B (ILE35) to (LYS94) 1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM
3utt:F (GLU212) to (TRP274) 1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM
3utt:G (ILE35) to (HIS84) 1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM
4kkc:C (PRO157) to (PRO220) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4kkc:E (PRO157) to (PRO220) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4z76:B (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z76:E (ASP34) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z77:B (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z77:E (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:B (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:E (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:H (ILE35) to (LYS94) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4kkl:E (PRO157) to (PRO220) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANPORT PROTEIN, MEMBRANE PROTEIN
4z7n:H (PRO155) to (LYS215) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4z7v:B (GLN126) to (ARG189) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7v:D (GLN126) to (TRP188) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7w:D (GLN126) to (ARG189) T316 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
3hr5:H (PRO153) to (PRO217) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
3hr5:B (PRO153) to (PRO217) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
3hr5:J (PRO153) to (PRO217) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
1s3k:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE | IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM
4zak:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
1s5i:H (PRO151) to (PRO227) FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL STRUCTURE, IMMUNE SYSTEM
3huj:H (HIS157) to (TRP243) CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR | CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
2fse:D (ILE127) to (LYS189) CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN | RHEUMATOID ARTHRITIS, HLA-DR1, COLLAGEN TYPE II, CRYSTAL STRUCTURE, ANTIGEN PRESENTATION, IMMUNE SYSTEM, STRUCTURAL PROTEIN
1ggt:B (VAL663) to (ARG727) THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII | BLOOD COAGULATION
1ggu:A (TRP664) to (ARG727) HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, TRANSFERASE
1ggu:B (VAL663) to (ARG727) HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, CALCIUM, TRANSFERASE
1ggy:A (ASN662) to (ARG727) HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, YTTERBIUM, TRANSFERASE
1ggy:B (VAL663) to (ARG727) HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE | TRANSGLUTAMINASE, BLOOD COAGULATION, YTTERBIUM, TRANSFERASE
1s7x:H (HIS34) to (TYR94) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s8d:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE- MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1s9x:B (ILE35) to (HIS84) CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2 | IMMUNE SYSTEM
1s9y:B (ILE35) to (LYS94) CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2 | IMMUNE SYSTEM
4zez:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX | HCV TCR, HLA-A2, HCV NS3:1406-1415 PEPTIDE, DECAPEPTIDE, PROTEIN BINDING, IMMUNE SYSTEM COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4zfg:H (PRO149) to (GLU212) DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2 | FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
2vl5:A (PRO155) to (PRO218) STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1 | RHEUMATOID FACTOR, IMMUNE SYSTEM, ARTHRITIS, AUTOANTIBODIES, COLLAGEN TYPE II
1seb:B (SER126) to (ARG189) COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB | HISTOCOMPATIBILITY ANTIGEN, MHC II, SUPERANTIGEN, ENTEROTOXIN PEPTIDE, TOXIN, COMPLEX (MHC II/PEPTIDE/TOXIN) COMPLEX
1seb:F (SER126) to (ARG189) COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB | HISTOCOMPATIBILITY ANTIGEN, MHC II, SUPERANTIGEN, ENTEROTOXIN PEPTIDE, TOXIN, COMPLEX (MHC II/PEPTIDE/TOXIN) COMPLEX
4zfo:H (PRO156) to (PRO220) J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269) | ANTIBODY FAB-LIGAND COMPLEX ANTI-BCMA ANTI-TUMOR, IMMUNE SYSTEM
2vlj:E (HIS154) to (ASP244) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vlk:B (ILE35) to (LYS94) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vlk:E (HIS154) to (ASP244) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vll:B (ILE35) to (LYS94) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX
2vll:E (ILE35) to (LYS94) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX
2vlr:B (ILE35) to (LYS94) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vlr:G (ILE35) to (LYS94) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vlr:J (HIS154) to (TRP240) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2fx7:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2fx9:I (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
3v5d:B (ILE35) to (LYS94) HLA-A2.1 KVAELVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5d:E (ILE35) to (LYS94) HLA-A2.1 KVAELVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5k:B (ASP34) to (LYS94) HLA2.1 KVAELVWFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5k:E (ASP34) to (LYS94) HLA2.1 KVAELVWFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
1gnh:A (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:B (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:C (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:E (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:F (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:G (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:H (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
1gnh:I (PHE33) to (LEU83) HUMAN C-REACTIVE PROTEIN | PENTRAXIN, ACUTE-PHASE REACTANT, ACUTE-PHASE PROTEIN
4kq4:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2fyy:B (ASP34) to (HIS84) THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION | MHC, HLA-B*3501, IG DOMAIN, IMMUNE SYSTEM
2fz3:B (ASP34) to (LYS94) THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION | MHC, HLA-B*3508, IG DOMAIN, IMMUNE SYSTEM
3v6o:D (PRO155) to (PRO218) LEPTIN RECEPTOR-ANTIBODY COMPLEX | RECEPTOR-ANTIBODY COMPLEX, CYTOKINE RECEPTOR, ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, LEPTIN RECEPTOR-ANTIBODY COMPLEX, IMMUNE SYSTEM
4kro:D (PRO155) to (GLU218) NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR | CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4krp:D (PRO155) to (GLU218) NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR | CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
3i3b:B (ARG255) to (ASP329) E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON | BETA-GALACTOSIDASE, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN BETA SUPERSANDWHICH, GLYCOSIDASE, HYDROLASE
3i3d:A (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG | BETA-GALACTOSIDASE, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN BETA SUPERSANDWHICH, GLYCOSIDASE, HYDROLASE
3vcl:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL | CLASS I HISTOCOMPATIBILITY ANTIGEN, ANTIGEN PRESENTATION, T-CELL RECEPTOR, MEMBRANE, IMMUNE SYSTEM
3i6g:B (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6g:E (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6k:B (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6k:F (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6l:E (ILE35) to (LYS94) NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402 | HLA-A*2402, SARS-COV, NUCLEOCAPSID PROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, GOLGI APPARATUS, PHOSPHOPROTEIN, RIBONUCLEOPROTEIN, RNA-BINDING, VIRAL NUCLEOPROTEIN, VIRION, IMMUNE SYSTEM
2vwe:L (PRO149) to (PRO212) CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM, GLYCOPROTEIN, CYSTEINE-KNOT, GROWTH FACTOR, VEGF-B, MITOGEN, SECRETED, ANGIOGENESIS, NEUTRALIZING ANTIBODY, HEPARIN-BINDING, ALTERNATIVE SPLICING
2vxu:I (PRO149) to (PRO212) CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT | FAB, IL-18, AUTOIMMUNITY, TH1/TH2 CELLS, IMMUNE SYSTEM
2vxv:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT | IMMUNE SYSTEM, IL-18, FAB, TH1/TH2 CELLS, AUTOIMMUNITY
2gfb:P (PRO151) to (PRO225) CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY | IMMUNOGLOBULIN
4kzd:H (PRO161) to (PRO225) CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IN VITRO, IMMUNE SYSTEM-RNA COMPLEX
1gzq:B (ILE35) to (LYS94) CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL | PHOPHATIDYLINOSITOL, MHC, GLYCOPROTEIN, ANTIGEN PRESENTATION
1sys:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY | HLA, MHC, CLASS I, B44, IMMUNE SYSTEM
1syv:B (ASP34) to (LYS94) HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF | HLA, MHC, CLASS I, B44, IMMUNE SYSTEM
3vfm:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A, HLA MUTANT ALA155 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfo:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A, HLA MUTANT ALA157 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfp:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G, HLA MUTANT GLY158 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfr:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA, PEPTIDE MUTANT P4-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfs:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA , PEPTIDE MUTANT P5-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vft:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA, PEPTIDE MUTANT P6-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfv:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA, PEPTIDE MUTANT P9-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfw:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA, PEPTIDE MUTANT P10-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
1t04:D (PRO153) to (PRO217) THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP | ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, THREE-DIMENSIONAL STRUCTURE, GAMMA- INTERFERON, IMMUNE SYSTEM
3iap:B (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q) | GLU-416-GLN BETA-GALACTOSIDASE HYDROLASE TIM BARREL(ALPHA/BETA BARREL) JELLY-ROLL BARREL IMMUNOGLOBULIN BETA SUPERSANDWHICH, GLYCOSIDASE, HYDROLASE
3vh8:B (ILE35) to (LYS94) KIR3DL1 IN COMPLEX WITH HLA-B*5701 | IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM
3vh8:E (ILE35) to (LYS94) KIR3DL1 IN COMPLEX WITH HLA-B*5701 | IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM
1t0m:B (HIS34) to (TYR94) CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE | IMMUNOGLOBULIN DOMAIN, MHC CLASS I ALPHA DOMAINS, HSV PEPTIDE, IMMUNE SYSTEM
1t0m:E (HIS34) to (TYR94) CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE | IMMUNOGLOBULIN DOMAIN, MHC CLASS I ALPHA DOMAINS, HSV PEPTIDE, IMMUNE SYSTEM
1t0n:B (HIS34) to (TYR94) CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE | IMMUNOGLOBULIN DOMAIN, MHC CLASS I ALPHA DOMAINS, HSV PEPTIDE, IMMUNE SYSTEM
1t0n:E (HIS34) to (TYR94) CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE | IMMUNOGLOBULIN DOMAIN, MHC CLASS I ALPHA DOMAINS, HSV PEPTIDE, IMMUNE SYSTEM
1t1w:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t1x:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t1z:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t20:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t21:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t22:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
2git:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE | HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, IMMUNE SYSTEM
2git:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE | HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, IMMUNE SYSTEM
3vk1:A (GLN141) to (ALA219) GREEN-FLUORESCENT VARIANT OF THE NON-FLUORESCENT CHROMOPROTEIN RTMS5 | GFP, ANTHOZOA, BETA CAN, BETA BARREL, FLUORESCENT PROTEIN, PIGMENT PROTEIN, PIGMENT, POCILLOPORIN, CHROMOPROTEIN, LUMINESCENT PROTEIN, FLUOROPHORE, CHROMOPHORE, ACYLIMINE
4l3e:B (ILE35) to (LYS94) THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26Y,BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE | RECEPTORS, MEMBRANE, IMMUNE SYSTEM
2vzo:A (GLY699) to (TRP766) CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
2vzo:B (LEU700) to (TRP766) CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
1h3u:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2 | IMMUNE SYSTEM, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS
1h3v:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121 | IMMUNOGLOBULIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM
1t4k:B (PRO151) to (PRO227) CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB | ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM
1h3x:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2 | IMMUNOGLOBIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM
2vzs:A (GLY699) to (TRP766) CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA | EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE, GH2, CSXA, GLUCOSAMINE, GLYCOSIDE HYDROLASE
2vzs:B (LEU700) to (TRP766) CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA | EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE, GH2, CSXA, GLUCOSAMINE, GLYCOSIDE HYDROLASE
4l4t:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4l4t:F (ILE35) to (LYS94) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4l4v:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4l4v:F (ASP34) to (LYS94) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
2vzt:A (GLY699) to (TRP766) COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
2vzt:B (GLY699) to (TRP766) COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
3idu:A (SER472) to (VAL540) CRYSTAL STRUCTURE OF THE CARDB DOMAIN OF THE PF1109 PROTEIN IN COMPLEX WITH DI-METAL IONS FROM PYROCOCCUS FURIOSUS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PFR193A | ALL BETA-PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
3idx:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3idy:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3idy:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
1t66:H (PRO154) to (PRO217) THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. | ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM
3if1:B (PRO149) to (PRO212) CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC | GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM
3if1:D (PRO149) to (PRO212) CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC | GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM
4zo6:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH CELLOBIOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zo6:B (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH CELLOBIOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zo7:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH GENTIOBIOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zo7:B (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH GENTIOBIOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zo8:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH SOPHOROSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zo8:B (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH SOPHOROSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zoa:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH ISOFAGOMINE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zoa:B (GLY638) to (GLY720) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH ISOFAGOMINE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zoc:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH SOPHOROTRIOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zod:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH GLUCOSE | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zoe:A (GLY638) to (GLY720) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM LISTERIA INNOCUA | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
4zoe:B (GLY638) to (GLY720) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE FROM LISTERIA INNOCUA | TIM BARREL, HYDROLASE, BETA-1, 2-GLUCAN DEGRADATION, CYTOSOL
1t89:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) | FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM
4l8c:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE | INFLUENZA, VIRAL ESCAPE, T CELL IMMUNITY, IMMUNE SYSTEM
4l8d:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE | INFLUENZA, VIRAL ESCAPE, T CELL IMMUNITY, IMMUNE SYSTEM
4lcc:C (GLU322) to (GLN381) CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1 | IMMUNOGLOBULIN DOMAIN, MHC-CLASS I-LIKE, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, B VITAMINS METABOLITES, CELL MEMBRANE, IMMUNE SYSTEM
4zs6:H (PRO157) to (PRO221) RECEPTOR BINDING DOMAIN AND FAB COMPLEX | COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM
4zs6:C (PRO157) to (PRO221) RECEPTOR BINDING DOMAIN AND FAB COMPLEX | COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM
2gtz:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gtz:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
4zso:B (PRO157) to (ILE218) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY | TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM
4zso:D (PRO157) to (ASP215) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY | TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM
4lcw:B (ILE35) to (LYS94) THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH | MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4lcw:F (ILE35) to (LYS94) THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH | MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
2guo:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2guo:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
4lcy:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION | ANTIGEN PRESENTING, CELL SURFACE, HLA-B46, MEMBRANE PROTEIN
2w60:A (PRO154) to (LYS214) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 | ANTIBODY ANTI-CITRULLIN, ARTHRITIS, IMMUNE SYSTEM
3ilq:D (ILE35) to (TRP95) STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI | ANTIGEN PRESENTATION, INKT CELLS, HOST DEFENSE, BORRELIA BURGDORFERI, CD1, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, IMMUNE SYSTEM
2w65:A (PRO154) to (PRO217) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
2w65:C (PRO154) to (PRO217) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
3inu:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY. | ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3inu:M (PRO151) to (PRO227) CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY. | ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4ztp:H (PRO148) to (PRO209) FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION | HIV-1, ENV, C4, CD4, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4lfh:D (ASP149) to (SER202) CRYSTAL STRUCTURE OF 9C2 TCR | NKT CELLS, GAMMADELTA TCR, CD1D, LIPID RECOGNITION, PBS-44, IMMUNE SYSTEM
4zuv:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12 | LENTIVIRUS VACCINE, IMMUNE SYSTEM
4zuv:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12 | LENTIVIRUS VACCINE, IMMUNE SYSTEM
2h26:B (ILE35) to (LYS94) HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER | LIPID, ENDOGENOUS LIGAND, PHOSPHATIDYLCHOLINE, MHC, ANTIGEN PRESENTATION, GLYCOPROTEIN, IMMUNE SYSTEM
1hhg:B (ILE35) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhg:E (ILE35) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhh:B (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhi:B (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhi:E (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhj:B (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhj:E (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhk:B (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhk:E (ASP34) to (LYS94) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
4lhu:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D | NKT CELLS, GAMMADELTA TCR, CD1D, LIPID RECOGNITION, PBS-44, IMMUNE SYSTEM
2w9d:H (PRO151) to (LYS211) STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION. | IMMUNE SYSTEM, PRION, PRP, FAB
1hil:B (PRO151) to (PRO227) STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION | IMMUNOGLOBULIN
1him:L (PRO151) to (PRO227) STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION | IMMUNOGLOBULIN
4ljd:C (LEU137) to (ALA216) STRUCTURE OF A PHOTOBLEACHED STATE OF IRISFP UNDER LOW INTENSITY LASER-LIGHT | FLUORESCENT PROTEIN, PHOTOBLEACHING, BETA-BARREL, OXIDATION
1tmc:B (ILE35) to (LYS94) THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN | HISTOCOMPATIBILITY ANTIGEN
2h6p:B (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY | IMMUNE SYSTEM, GENE REGULATION
1hoc:B (ILE35) to (TYR94) THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION | HISTOCOMPATIBILITY ANTIGEN
1hql:A (SER4) to (PHE92) THE XENOGRAFT ANTIGEN IN COMPLEX WITH THE B4 ISOLECTIN OF GRIFFONIA SIMPLICIFOLIA LECTIN-1 | GRIFFONIA SIMPLICIFOLIA, LECTIN, XENOGRAFT ANTIGEN, SUGAR BINDING PROTEIN
1hql:B (SER4) to (PHE92) THE XENOGRAFT ANTIGEN IN COMPLEX WITH THE B4 ISOLECTIN OF GRIFFONIA SIMPLICIFOLIA LECTIN-1 | GRIFFONIA SIMPLICIFOLIA, LECTIN, XENOGRAFT ANTIGEN, SUGAR BINDING PROTEIN
4lkc:B (PRO164) to (PRO228) AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO | IMMUNOGLOBULIN, ANTIBODY, PCSK9, IMMUNE SYSTEM
2hff:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF CB2 FAB | FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM
3ixa:E (ASP34) to (HIS84) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE | TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
2hfg:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB | FAB FRAGMENT, TNFRSF, ANTIBODY-RECEPTOR COMPLEX, CRD, IMMUNE SYSTEM
1hqr:B (SER326) to (ARG389) CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II | SUPERANTIGEN-MHC CLASS II COMPLEX, IMMUNE SYSTEM
3ixt:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
3ixt:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
1hsb:B (ILE35) to (LYS94) DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE | HISTOCOMPATIBILITY ANTIGEN, IMMUNE SYSTEM
1tvb:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; GP100; PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
1tvb:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; GP100; PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
1tvh:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; MODIFIED GP100 PEPTIDE; GP100(209-T2M) PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
1tvh:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; MODIFIED GP100 PEPTIDE; GP100(209-T2M) PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
4lly:A (PRO155) to (PRO219) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A | FAB, IMMUNE SYSTEM
4lly:C (PRO155) to (PRO219) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A | FAB, IMMUNE SYSTEM
4lmf:A (VAL55) to (ALA114) C1S CUB1-EGF-CUB2 | CUB DOMAIN, EGF-LIKE DOMAIN, COMPLEMENT C1S, HYDROLASE
4lmf:C (SER54) to (ALA114) C1S CUB1-EGF-CUB2 | CUB DOMAIN, EGF-LIKE DOMAIN, COMPLEMENT C1S, HYDROLASE
3vri:B (ILE35) to (LYS94) HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR | HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR
3vrj:B (ILE35) to (ARG97) HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR | HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR
2hjk:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE | B57, HLA, HIV, IMMUNE SYSTEM
5a16:C (PRO159) to (LYS219) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:G (PRO159) to (LYS219) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
2hla:B (ILE35) to (LYS94) SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 | HISTOCOMPATIBILITY ANTIGEN
2hlf:E (PRO157) to (PRO220) STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNELS AND TRANSPOTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX, PROTON TRANSPORT,MEMBRANE PROTEIN
4lnr:B (ASP34) to (LYS94) THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY) | HETEROTRIMER, LIGAND FOR T CELL RECEPTOR, IMMUNE SYSTEM
2hn7:B (ILE35) to (LYS94) HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE | PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, HEPATITIS B VIRUS, HBV, IMMUNE SYSTEM
4lou:C (PRO157) to (HIS207) STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | CL-/H+ ANTIPORTER, MEMBRANE PROTEIN, TRANPORT PROTEIN
1tzg:I (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 | ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
1tzh:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF | PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM
1tzi:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF | PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM
3vw3:H (PRO151) to (ARG228) ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT | PROTEIN-DNA COMPLEX, DNA (6-4) PHOTOPRODUCT, IMMUNOGLOBULIN, IMMUNE SYSTEM-DNA COMPLEX
3vwj:B (ILE35) to (LYS94) TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX | CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4lri:P (PRO166) to (PRO230) ANTI CMV FAB FRAGMENT | FAB FRAGMENT, CMV NEUTRALIZING ANTIBODY, GLYCOPROTEIN H OR GH FROM CMV, IMMUNE SYSTEM
1i1y:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
1i1y:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
3vxm:B (ASP34) to (LYS94) THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxn:B (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxo:B (ASP34) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxp:B (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxp:E (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxr:B (ILE35) to (LYS94) THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxs:B (ILE35) to (LYS94) THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxt:D (HIS151) to (ALA240) T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
2wng:A (PRO35) to (LYS116) COMPLETE EXTRACELLULAR STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA | SIGNAL REGULATORY PROTEIN ALPHA, IMMUNOGLOBULIN SUPERFAMILY, PHOSPHOPROTEIN, DISULFIDE BOND, PAIRED RECEPTOR, ALTERNATIVE SPLICING, IMMUNOGLOBULIN DOMAIN, SIRP, CD47, SIRPA, MEMBRANE, SH3-BINDING, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE, CELL ADHESION
2wng:A (ARG251) to (LEU316) COMPLETE EXTRACELLULAR STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA | SIGNAL REGULATORY PROTEIN ALPHA, IMMUNOGLOBULIN SUPERFAMILY, PHOSPHOPROTEIN, DISULFIDE BOND, PAIRED RECEPTOR, ALTERNATIVE SPLICING, IMMUNOGLOBULIN DOMAIN, SIRP, CD47, SIRPA, MEMBRANE, SH3-BINDING, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE, CELL ADHESION
1i3r:B (ASN152) to (ALA216) CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE | MHC CLASSII, IMMUNE SYSTEM
1i3r:F (ASN152) to (ALA216) CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE | MHC CLASSII, IMMUNE SYSTEM
1i3r:H (ASN152) to (ALA216) CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE | MHC CLASSII, IMMUNE SYSTEM
4lss:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120 | ANTIBODY ANTIGEN COMPLEX, NEUTRALIZING ANTIBODY VRC01, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4lst:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120 | NEUTRALIZING ANTIBODY VRC01, HIV ENVELOPE GLYCOPROTEIN GP120, ANTIBODY ANTIGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3w0w:B (ILE35) to (ARG97) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121 | HIV-1, NEF, HLA-A24, T CELL RECEPTOR, MHC CLASS I, TCR, MHC, IMMUNOGLOBURIN DOMAIN, IMMUNE SYSTEM, IMMUNE RESPONSE
3w0w:E (HIS151) to (TRP237) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121 | HIV-1, NEF, HLA-A24, T CELL RECEPTOR, MHC CLASS I, TCR, MHC, IMMUNOGLOBURIN DOMAIN, IMMUNE SYSTEM, IMMUNE RESPONSE
1i4f:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, MELANOMA-ASSOCIATED ANTIGEN, IMMUNE SYSTEM
2ht2:C (PRO157) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2htk:E (PRO157) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
4lu5:H (PRO149) to (PRO212) STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
5a3i:G (PRO161) to (PRO225) CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ | VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN
4lvh:K (PRO157) to (LYS218) INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ | INFLUENZA VIRUS, IMMUNE SYSTEM, HEMAGGLUTININ, ANTIBODY
3w39:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI) | CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, MEMBRANE, IMMUNE SYSTEM
3w39:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI) | CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, MEMBRANE, IMMUNE SYSTEM
1i7r:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 | MHC FOLD, IMMUNE SYSTEM
1i7r:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 | MHC FOLD, IMMUNE SYSTEM
1i7u:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V | MHC FOLD, IMMUNE SYSTEM
1i7u:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V | MHC FOLD, IMMUNE SYSTEM
1ub5:H (PRO152) to (LYS212) CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K | ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM
1ub5:A (PRO152) to (LYS212) CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K | ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM
1iai:H (PRO157) to (ASP219) IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX | COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A)
1iai:I (PRO157) to (ILE218) IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX | COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A)
1iak:B (LYS126) to (ALA190) HISTOCOMPATIBILITY ANTIGEN I-AK | HISTOCOMPATIBILITY ANTIGEN, MHC, PEPTIDE COMPLEX, HISTOCOMPATIBILITY ANTIGEN I-AK
1iao:B (LYS126) to (SER2) CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339 | MHC II, CLASS II MHC, I-A, OVALBUMIN PEPTIDE
1ucb:H (PRO151) to (PRO227) STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ) | FAB, IMMUNOGLOBULIN, ANTIBODY, ANTI-TUMOR, CHIMERA
5a59:A (ALA1129) to (PHE1212) THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH T-ANTIGEN | HYDROLASE, GLYCOSIDE HYDROLASE FAMILY 101, GH101, T-ANTIGEN, MUCIN DEGRADATION
1iea:D (ASN126) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN
1ieb:B (ILE127) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN
1ieb:D (ILE127) to (TRP188) HISTOCOMPATIBILITY ANTIGEN | HISTOCOMPATIBILITY ANTIGEN
1igt:B (PRO151) to (PRO227) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN
1igt:D (PRO151) to (PRO227) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN
1igy:B (PRO151) to (PRO227) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN
1igy:D (PRO151) to (PRO227) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN
1uj3:B (PRO453) to (SER517) CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR | TISSUE FACTOR, ANTIGEN, ANTIBODY, FAB, IMMUNE SYSTEM/BLOOD CLOTTING COMPLEX
2i5y:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5a7x:N (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:P (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:R (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a8h:F (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:L (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:R (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
1im3:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:J (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:N (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
3w9d:A (PRO158) to (GLU221) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
3w9d:C (PRO158) to (PRO222) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
3w9e:A (PRO158) to (PRO222) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD | IGG FOLD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1im9:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN DOMAIN, ANTIPARALLEL BETA SHEET, ALPHA HELIX, IMMUNE SYSTEM
1im9:F (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN DOMAIN, ANTIPARALLEL BETA SHEET, ALPHA HELIX, IMMUNE SYSTEM
1um4:H (PRO155) to (PRO219) CATALYTIC ANTIBODY 21H3 WITH HAPTEN | CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM
1um5:H (PRO155) to (PRO219) CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE | CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM
1um6:H (PRO155) to (PRO219) CATALYTIC ANTIBODY 21H3 | CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM
2iam:B (SER126) to (ARG189) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ian:L (SER126) to (ARG189) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ian:O (HIS150) to (TRP236) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ian:T (HIS150) to (TRP236) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
4m6o:H (PRO159) to (PRO223) CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
1uow:A (GLY306) to (GLY379) CALCIUM BINDING DOMAIN C2B | GLYCOPROTEIN, LIPOPROTEIN, TRANSMEMBRANE
4m7k:H (PRO156) to (PRO220) CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10 | ANTIBODY, IMMUNE SYSTEM
4m7z:B (PRO149) to (PRO212) UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB | BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM
4m7z:H (PRO149) to (PRO212) UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB | BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM
1uqs:B (ILE35) to (LYS94) THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID | GLYCOPROTEIN, LIPID, GMM, CD1B, MHC, ANTIGEN PRESENTATION
4m8v:A (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN DOUBLE MUTANT BETA2-MICROGLOBULIN Q8H-L65T | IMMUNE SYSTEM
4m8v:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN DOUBLE MUTANT BETA2-MICROGLOBULIN Q8H-L65T | IMMUNE SYSTEM
4ma3:H (PRO150) to (PRO214) CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
4ma3:B (PRO150) to (PRO214) CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
3j2p:A (CYS333) to (LYS394) CRYOEM STRUCTURE OF DENGUE VIRUS ENVELOPE PROTEIN HETEROTETRAMER | FLAVIVIRUS, FUSION PROTEIN, PROTEIN COMPLEX, MEMBRANE, VIRAL PROTEIN
3j2p:C (CYS333) to (LYS394) CRYOEM STRUCTURE OF DENGUE VIRUS ENVELOPE PROTEIN HETEROTETRAMER | FLAVIVIRUS, FUSION PROTEIN, PROTEIN COMPLEX, MEMBRANE, VIRAL PROTEIN
4mae:B (ARG287) to (PRO345) METHANOL DEHYDROGENASE FROM METHYLACIDIPHILUM FUMARIOLICUM SOLV | DEHYDROGENASE, PQQ, LANTHANIDE ION, CERIUM ION, OXIDOREDUCTASE
4may:B (GLN126) to (ARG189) CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX | IMMUNE COMPLEX, AUTOIMMUNITY, MULTIPLE SCLEROSIS, ANTIGEN PRESENTATION, IMMUNE SYSTEM
5ad0:B (ILE34) to (ASP95) COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE | IMMUNE SYSTEM, CHICKEN, B21
2x09:A (GLY699) to (THR769) INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE | EXO-BETA-D-GLUCOSAMINIDASE, GLYCOSIDE HYDROLASE, GH2, CSXA, HYDROLASE, GLYCOSIDASE
2x09:B (GLY699) to (TRP766) INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE | EXO-BETA-D-GLUCOSAMINIDASE, GLYCOSIDE HYDROLASE, GH2, CSXA, HYDROLASE, GLYCOSIDASE
3we6:A (PRO153) to (LYS213) CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT | IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, IMMUNE SYSTEM
5ado:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT | IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION
3wfh:A (PRO153) to (LYS213) CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX | IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, FAB FRAGMENT BY PAPAIN DIGESTION, IMMUNE SYSTEM
1uyw:M (PRO149) to (PRO212) CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2 | IMMUNE SYSTEM
1j0j:B (ASP35) to (THR98) CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE | BETA-ALPHA-BARRELS, HYDROLASE
3wih:H (PRO155) to (PRO218) CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A. | FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM
3wih:I (PRO155) to (PRO218) CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A. | FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM
2x4o:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2x4o:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2x4p:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4p:E (ILE35) to (ARG97) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4q:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE
2x4q:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE
2x4r:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE | IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4r:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE | IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4s:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN | PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4s:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN | PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4t:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE | MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4t:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE | MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4u:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2x4u:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
3wkm:I (PRO159) to (LYS218) THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT | PDZ DOMAIN, HYDROLASE
2x70:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION
2x70:E (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION
3wl9:B (ILE35) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F) | HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR
3wlb:B (ASP34) to (LYS94) HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F) | HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR
4mj5:B (ILE35) to (LYS94) HLA-A11 COMPLEXED WITH A PEPITDE | MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX
4mj6:B (ILE35) to (LYS94) HLA-A11 COMPLEXED WITH A MUTATED PEPTIDE | MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX
4mji:B (ILE35) to (LYS94) T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01 | HIV, PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, SURFACE PLASMON RESONANCE, SPR, T-CELL, T-CELL RECEPTOR, TCR, IMMUNOGLOBULIN, CLASS I MHC, ANTIGEN PRESENTATION, IMMUNE SYSTEM
4mji:G (ILE35) to (ARG97) T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01 | HIV, PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, SURFACE PLASMON RESONANCE, SPR, T-CELL, T-CELL RECEPTOR, TCR, IMMUNOGLOBULIN, CLASS I MHC, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3wlw:H (PRO153) to (PRO217) MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER | HYDROLASE-IMMUNE SYSTEM COMPLEX
1vb9:A (VAL35) to (GLY97) CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT | (BETA/ALPHA)8 BARREL, GH FAMILY 13, HYDROLASE
4mnh:D (GLN150) to (SER209) STRUCTURE OF THE DP10.7 TCR | IMMUNOGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, T CELL RECEPTOR, IMMUNOLOGICAL, LYMPHOCYTES, T CELL RECOGNITION, ACTIVATION, GAMMA DELTA T CELL, HUMAN, INTRAEPITHELIAL LYMPHOCYTES, CD1D, GLYCOLIPIDS, NON-CLASSICAL MHC, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
4mnq:B (ILE35) to (HIS84) TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS | SURFACE PLASMON RESONANCE (SPR); BIACORETM; PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX (PMHC): T-CELL RECEPTOR (TCR), T-CELLS; HIGH AFFINITY TCR, TWO-STEP BINDING, ADOPTIVE THERAPY, IMMUNOGLOBULIN, ADAPTIVE IMMUNE RESPONSE, IMMUNE SYSTEM
1jgd:B (ILE35) to (LYS94) HLA-B*2709 BOUND TO DECA-PEPTIDE S10R | MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM
1jht:B (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A. | HUMAN, TUMOR IMMUNITY, MELANOMA ANTIGEN, MHC, VACCINATION, MELANOMA, CLASS I, IMMUNE SYSTEM
1ji2:B (VAL35) to (GLY97) IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 | BETA/ALPHA BARREL, HYDROLASE
1jib:A (VAL35) to (GLY97) COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE. | PULLULAN, CYCLODEXTRIN, NEOPULLULANASE, MALTOHEXAOSE, MALTOTETRAOSE, HYDROLASE
1vfm:B (VAL35) to (GLY97) CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX | AMYLASE, COMPLEX, CYCLODEXTRIN, HYDROLASE
4mq7:B (ILE35) to (ASP98) STRUCTURE OF HUMAN CD1D-SULFATIDE | GAMMA-DELTA, T CELL RECEPTOR, HUMANS, T CELLS, NON-CLASSICAL, LIPIDS, CD1D, RESTRICTION, IMMUNOGLOBULIN, MAJOR HISTOCOMPATIBILITY COMPLEX, ANTIGEN PRESENTATION, SELF-LIGANDS, IMMUNE SYSTEM
1jl4:B (LYS126) to (ALA190) CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE | PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM
5aum:H (PRO149) to (VAL212) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE | ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX
2j4w:H (PRO151) to (PRO227) STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, MEMBRANE, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, ANTIBODY CROSS- REACTIVITY, SURFACE ACTIVE PROTEIN, MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, IMMUNE SYSTEM
3ws6:D (HIS54) to (TYR114) CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE | CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, MIMOTOPE, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM
1jpg:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IG FOLD, IMMUNE SYSTEM
1jps:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44 | ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, INTERFACE WATER MOLECULES, CRYSTAL STRUCTURE, IMMUNE SYSTEM
1jrh:H (PRO151) to (LYS221) COMPLEX (ANTIBODY/ANTIGEN) | CYTOKINE RECEPTOR, COMPLEX (ANTIBODY/ANTIGEN), TRANSMEMBRANE, GLYCOPROTEIN
4mwf:A (PRO149) to (PRO213) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C | IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM
4mwf:H (PRO149) to (PRO213) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C | IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM
2j8u:B (ILE35) to (LYS94) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL
2j8u:I (ASP34) to (LYS94) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL
4mx7:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH DIOLEOYL-PHOSPHATIDIC ACID | MHC FOLD, ANTIGEN PRESENTATION, LIPID ANTIGEN, MEMBRANE, IMMUNE SYSTEM
4mxv:Y (PRO149) to (PRO213) STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
4mxw:W (PRO148) to (PRO212) STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
4mxw:H (PRO148) to (PRO212) STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
4n0c:D (HIS151) to (ASP241) 42F3 TCR PCPE3/H-2LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
4n0c:H (HIS151) to (ASP241) 42F3 TCR PCPE3/H-2LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
3x11:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS LILRS, TCRS, KIRS, PLASMA MEMBRANE, IMMUNE SYSTEM
3x14:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM
2xpg:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX | IMMUNE SYSTEM, AUTOIMMUNITY, MULTIPLE SCLEROSIS
3x2d:D (PRO164) to (PRO228) CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78 | MARBURG, GLYCOPROTEIN, ANTIBODY, VIRUS, NEUTRALIZATION, FUSION, NIEMANN PICK C1 (NPC1) RECEPTOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2jb6:A (THR150) to (PRO213) FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2 | CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM
2xqy:G (PRO149) to (PRO212) CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ENVELOPE PROTEIN
2xqy:J (PRO149) to (PRO212) CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ENVELOPE PROTEIN
2jcc:B (ILE35) to (LYS94) AH3 RECOGNITION OF MUTANT HLA-A2 W167A | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN
2jcc:I (ASP34) to (LYS94) AH3 RECOGNITION OF MUTANT HLA-A2 W167A | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN
2xra:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX | IMMUNE SYSTEM, ANTIBODY, MONOCLONAL CELLS, NEUTRALIZATION TESTS
1jyx:A (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG | TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, HYDROLASE
5b39:B (ILE35) to (LYS94) KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01 | INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM
3zdx:H (PRO155) to (LYS215) INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX | CELL ADHESION-IMMUNE SYSTEM COMPLEX
5bmf:H (PRO1035) to (PRO1099) CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT | ANTIBODY, HAPTEN BINDING, THEOPHYLLINE, IMMUNE SYSTEM
1jz5:B (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON | TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, HYDROLASE
2xtj:E (PRO167) to (PRO231) THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB | HYDROLASE-ANTIBODY COMPLEX, SERINE PROTEASE, LDL-C, LDLR, EGF-A, HYPERCHOLESTEROLEMIA
1w72:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3 | IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I
1w72:E (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3 | IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I
5bo1:H (PRO152) to (PRO216) CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB | JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5bo1:I (PRO152) to (PRO216) CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB | JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
1jz7:C (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE | TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, HYDROLASE
2jht:B (LYS127) to (LYS199) CRYSTAL STRUCTURE OF RHOGDI K135T,K138T,K141T MUTANT | SURFACE ENTROPY REDUCTION, INHIBITOR, GTPASE ACTIVATION, CRYSTAL ENGINEERING
4n8v:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A | ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM
4n8v:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A | ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM
4n90:D (PRO158) to (PRO222) CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL, DR5, AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY | DR5, TRAIL, AGONIST, ANTIBODY, COOPERATION, CLUSTERING, APOPTOSIS- IMMUNE SYSTEM COMPLEX
5brz:B (ILE35) to (LYS94) MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1 | IMMUNO PMHC TCR MAGE, IMMUNE SYSTEM
5bs0:B (ILE35) to (LYS94) MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1 | IMMUNO PMHC TCR TITIN, IMMUNE SYSTEM
1wbx:B (HIS34) to (TYR94) CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE | MHC CLASS I, INFLUENZA PEPTIDE, HA468, IMMUNE SYSTEM
1wbz:B (HIS34) to (TYR94) CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE | MHC CLASS I, INFLUENZA PEPTIDE, HA468, IMMUNE SYSTEM
1wbz:D (HIS34) to (TYR94) CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE | MHC CLASS I, INFLUENZA PEPTIDE, HA468, IMMUNE SYSTEM
1wc7:H (PRO149) to (ILE210) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE | ANTIBODY, CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, PHOSPHOPYRIDOXYL-L-ALANINE
1k5n:B (ILE35) to (LYS94) HLA-B*2709 BOUND TO NONA-PEPTIDE M9 | MHC(MAJOR HISTOCOMPATIBILITY COMPLEX), HLA(HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM
5bvj:D (PRO154) to (PRO218) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bvj:F (PRO154) to (PRO218) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
1k8d:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE | CRYSTAL STRUCTURE, NON-CLASSICAL MHC CLASS I, ANTIGEN PRESENTATION, PREIMPLANTATION EMBRYO DEVOLEPMENT GENE PRODUCT, QA-2, Q9, IMMUNE SYSTEM
5bxf:B (ILE35) to (LYS94) APO FCRN STRUCTURE AT PH 4.5 | FCRN, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
5bxf:D (ILE35) to (LYS94) APO FCRN STRUCTURE AT PH 4.5 | FCRN, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
5bxg:A (THR113) to (LYS184) CRYSTAL STRUCTURE OF AN UNCHARACTERIZED BETA-SANDWICH PROTEIN (CD630_09570) FROM CLOSTRIDIUM DIFFICILE 630 AT 1.90 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN FUNCTION
4nhg:Y (ASP376) to (LEU443) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:N (ASP376) to (LEU443) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:P (ASP376) to (LEU443) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhh:B (ASP376) to (LEU443) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:D (ASP376) to (LEU443) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:N (ASP376) to (LEU443) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
3zkm:C (PRO152) to (LYS212) BACE2 FAB COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX
3zkm:H (PRO152) to (PRO215) BACE2 FAB COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX
3zkn:C (PRO152) to (PRO215) BACE2 FAB INHIBITOR COMPLEX | IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX
3zkn:H (PRO152) to (PRO215) BACE2 FAB INHIBITOR COMPLEX | IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX
1kc5:H (PRO152) to (PRO215) CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN, COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
5bzd:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF PCDN-27A, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES | HIV, ANTIBODY, FAB, IMMUNE SYSTEM
5c07:B (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c07:F (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c07:G (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c08:B (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c08:E (HIS156) to (ALA245) 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c08:G (ILE35) to (ARG97) 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0b:B (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0b:G (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c09:B (ILE35) to (LYS94) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c09:E (HIS156) to (TRP242) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c09:G (ILE35) to (LYS94) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0a:A (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0a:B (ILE35) to (ARG97) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0a:G (ILE35) to (ARG97) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
4nm4:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 | IMMUNE SYSTEM, IMMUNE RECOGNITION, ANTIBODY, FAB, IMMUNOGLOBULIN, INFLUENZA HEMAGGLUTININ
5c0c:B (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0c:G (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0d:B (ILE35) to (LYS94) HLA-A02 CARRYING AQWGPDPAAA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0e:B (ILE35) to (LYS94) HLA-A02 CARRYING YLGGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0f:B (ILE35) to (LYS94) HLA-A02 CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0h:B (ILE35) to (LYS94) HLA-A02 CARRYING MVWGPDPLYV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-RTEACTIVITY, IMMUNE SYSTEM
4nm8:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
5c0i:B (ILE35) to (LYS94) HAL-A02 CARRYING RQFGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0j:B (ILE35) to (LYS94) HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0s:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261 | HEMAGGLUTININ, IMMUNOGEN, TRIMER, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3zo0:A (ASP376) to (ARG443) MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY | IMMUNE SYSTEM-LIGASE COMPLEX
4nnp:H (PRO164) to (PRO228) CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT | ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4nnp:X (PRO164) to (PRO228) CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT | ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4nnx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, POST TRANSLATIONAL MODIFICATION, TUMOR IMMUNOLOGY, TUMOR ANTIGENS, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
1kj2:L (ILE35) to (TYR94) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM
4no0:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 | NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, LILRB1, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
1kj3:L (HIS34) to (TYR94) MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE | MHC CLASS I, H-2KB, PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM
1kj3:M (HIS34) to (TYR94) MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE | MHC CLASS I, H-2KB, PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM
4no2:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, PEPTIDE-MHC COMPLEX, MHC, TUMOR IMMUNOLOGY, PEPTIDE CONFORMATION, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
1kjm:B (ILE35) to (TRP95) TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE | PEPTIDE-MHC COMPLEX, HETERODIMER, EXTRACELLULAR DOMAIN, IMMUNE SYSTEM
4no5:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGENS, IMMUNE SYSTEM-ANTIGEN COMPLEX
4np4:H (PRO155) to (PRO219) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
4np4:I (PRO155) to (PRO219) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
4nqc:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqc:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
1wzl:A (VAL35) to (GLY97) THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L | ALPHA-AMYLASE, PULLULAN, GH-13, ALPHA-AMYLASE FAMILY, HYDROLASE
4nqd:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqd:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqe:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqe:F (ASP34) to (ARG97) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqe:H (HIS155) to (GLU239) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
1kmt:A (LYS127) to (LYS200) CRYSTAL STRUCTURE OF RHOGDI GLU(154,155)ALA MUTANT | IMMUNOGLOBULIN FOLD, BETA SANDWICH MOTIF, ISOPRENYL-BINDING, PROTEIN BINDING
1kn2:H (PRO149) to (PRO223) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM
1kn4:H (PRO149) to (PRO223) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM
4nqu:A (ASP376) to (LEU443) ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqv:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqv:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqv:F (ASP34) to (ASP98) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqv:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqv:J (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqv:L (ILE35) to (TRP95) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:F (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:J (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:L (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3ztj:K (PRO145) to (PRO209) STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H3 INFLUENZA HAEMAGGLUTININ. | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, X31, MONOCLONAL ANTIBODY
4nrx:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrx:D (PRO166) to (PRO230) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nt6:B (ILE35) to (LYS94) HLA-C*0801 CRYSTAL STRUCTURE | CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-C1, HLA-C*08, EXTRACELLULAR, IMMUNE SYSTEM
2yew:I (LEU82) to (PRO125) MODELING BARMAH FOREST VIRUS STRUCTURAL PROTEINS | ALPHAVIRUS, VIRUS, MOLECULAR DYNAMICS
4nug:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151 | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE
4nuj:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152 | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE
1x7q:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE | PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, SARS, IMMUNE SYSTEM
1ksg:B (GLU72) to (VAL150) COMPLEX OF ARL2 AND PDE DELTA, CRYSTAL FORM 1 | SMALL GTPASE, SMALL GTP-BINDING PROTEIN, ARF FAMILY, EFFECTOR MOLECULE, IMMUNOGLOBULINE-LIKE FOLD, GDI, SIGNALING PROTEIN/HYDROLASE COMPLEX
4nwu:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF APE1551, AN ANTI-HUMAN NGF FAB WITH A NINE AMINO ACID INSERTION IN CDR H1 | BETA-SANDWICH, HUMAN BETA NERVE GROWTH FACTOR, IMMUNE SYSTEM
1kt2:D (ASN153) to (TRP215) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, CYTOCHROME, IMMUNE SYSTEM
1xcq:D (PRO154) to (ARG218) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A,L57H,Y64W) IN SPACE GROUP P21 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
2nlj:B (PRO154) to (LYS214) POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL | VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
5c9j:B (ILE36) to (LYS95) HUMAN CD1C WITH LIGANDS IN A' AND F' CHANNEL | ANTIGEN PRESENTATION, CD1, HUMAN CD1, MHC-LIKE, IMMUNOLOGY, LIPID ANTIGEN, IMMUNE SYSTEM
1xf4:H (PRO149) to (PRO212) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
1xf4:B (PRO149) to (LYS209) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
4o2c:B (ILE35) to (LYS94) AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2e:B (ILE35) to (LYS94) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2e:E (ILE35) to (LYS94) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2f:B (ASP34) to (LYS94) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2f:E (ILE35) to (LYS94) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
3jt0:B (MSE57) to (PHE132) CRYSTAL STRUCTURE OF THE C-TERMINAL FRAGMENT (426-558) LAMIN-B1 FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR5546A | CRYSTAL STRUCTURE, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, HR5546A, LMNB1_HUMAN, LAMIN-B1, ACETYLATION, CHROMOSOMAL REARRANGEMENT, COILED COIL, INTERMEDIATE FILAMENT, LEUKODYSTROPHY, LIPOPROTEIN, MEMBRANE, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, PRENYLATION, STRUCTURAL PROTEIN
4o4y:H (PRO150) to (PRO214) CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE | IMMUNOGLOBULIN FOLD, ANTIBODY, HINGE, IMMUNE SYSTEM
4o58:L (GLY142) to (PRO208) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3jtt:B (ILE36) to (LYS95) CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02 | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3jtt:E (ILE36) to (LYS95) CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02 | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3jtt:H (ILE36) to (LYS95) CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02 | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1xgp:B (PRO149) to (LYS209) STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A RESOLUTION, Y33A MUTANT, IMMUNE SYSTEM
1xgu:B (PRO149) to (LYS209) STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33F MUTANT, IMMUNE SYSTEM
1xh3:B (ILE35) to (LYS94) CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501 | IMMUNE SYSTEM
1l9m:B (CYS627) to (GLU692) THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION | ACTIVATION, CALCIUM BINDING, TRANSGLUTAMINASE, X-RAY STRUCTURE, TRANSFERASE
2ypk:B (ASP34) to (LYS94) STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS | IMMUNE SYSTEM, MICROPOLYMORPHISM
2ypl:B (ASP34) to (LYS94) STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM
5cex:A (GLY143) to (ALA208) CRYSTAL STRUCTURE OF FAB 32H+109L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES | HIV-1, IMMUNE SYSTEM, ANTIBODY
5cex:C (THR146) to (ALA208) CRYSTAL STRUCTURE OF FAB 32H+109L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES | HIV-1, IMMUNE SYSTEM, ANTIBODY
5cey:D (PRO147) to (PRO211) CRYSTAL STRUCTURE OF FAB 9H+3L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES | HIV-1, ANTIBODY, IMMUNE SYSTEM
2ypv:H (SER155) to (LYS215) CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY | IMMUNE SYSTEM, VACCINE, MONOCLONAL ANTIBODY, MAB, EPITOPE MAPPING
4oaw:B (PRO166) to (GLU229) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
2nw2:B (HIS157) to (ALA246) CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A | T CELL RECEPTOR, IMMUNE SYSTEM
2nw3:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | MHC, HLA-B*3508, IMMUNE SYSTEM
1ldp:L (ILE35) to (TRP95) CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES | COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNOLOGY, CELLULAR IMMUNITY, PEPTIDE ANTIGEN, CELL SURFACE RECEPTOR, ANTIGEN RECEPTOR, ANTIGEN PRESENTATION
2nx5:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM
5cin:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
4ocx:H (PRO152) to (PRO215) FAB COMPLEX WITH METHOTREXATE | IGG1/K FAMILY, IMMUNE SYSTEM
5cip:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF UNBOUND 4E10 | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
5cip:A (PRO151) to (PRO227) CRYSTAL STRUCTURE OF UNBOUND 4E10 | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
2nxz:D (PRO3164) to (PRO3228) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny1:D (PRO3164) to (PRO3228) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny3:D (PRO3164) to (PRO3228) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny4:D (PRO3164) to (PRO3228) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny7:H (PRO151) to (PRO227) HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12 | HIV, GP120, BROADLY NEUTRALIZING ANTIBODY, B12, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjq:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114 | HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4oe8:A (ASP151) to (SER226) INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 1 | DESIGNED ANTIPARALLEL TRIPLE-HELIX COILED-COIL, ALPHABODY, IMMUNOGLOBULIN DOMAIN, 4-HELICAL BUNDLE CYTOKINE, ANTAGONIST, N- LINKED GLYCOSYLATION, ALKYLATION, IMMUNE SYSTEM
2nyy:D (PRO154) to (PRO218) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
1lj7:A (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:B (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:C (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:D (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:E (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:F (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:G (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:H (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:I (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lj7:J (PHE33) to (LEU83) CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA | PENTRAXIN FOLD, PENTAMER, DECAMER, TWINNED, UNKNOWN FUNCTION
1lk3:H (PRO155) to (PRO218) ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM
2nz9:D (PRO154) to (PRO218) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
2nz9:F (PRO154) to (PRO218) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
4ogy:H (PRO158) to (PRO222) CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX
4ogy:M (PRO158) to (PRO222) CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX
4oi7:B (THR154) to (PRO232) RAGE RECOGNIZES NUCLEIC ACIDS AND PROMOTES INFLAMMATORY RESPONSES TO DNA | PROTEIN-DNA COMPLEX, IG FOLD, DNA BINDING, EXTRACELLULAR RECEPTOR, TRANSPORT PROTEIN,SIGNALING PROTEIN-DNA COMPLEX
4oi8:B (THR154) to (PRO232) RAGE IS A NUCLEIC ACID RECEPTOR THAT PROMOTES INFLAMMATORY RESPONSES TO DNA. | IG FOLD, DNA BINDING, TRANSPORT PROTEIN,SIGNALING PROTEIN-DNA COMPLEX
1lo0:Y (VAL156) to (PRO218) CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX | CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1lo2:Y (VAL156) to (PRO218) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY | CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM
1lo3:Y (PRO155) to (LYS215) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE | FAB, CATALYTIC ANTIBODY, PRODUCT COMPLEX, IMMUNE SYSTEM
2z6x:G (VAL137) to (GLY218) CRYSTAL STRUCTURE OF 22G, THE WILD-TYPE PROTEIN OF THE PHOTOSWITCHABLE GFP-LIKE PROTEIN DRONPA | GFP-LIKE PROTEIN, DRONPA, FLUORESCENT PROTEIN
1lp9:I (ILE35) to (LYS94) XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 | IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM
2z91:C (PRO149) to (PRO212) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 | IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM
4ojf:H (PRO149) to (PRO213) HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8 | AMYLOID, BAPINEUZUMAB, 3D6, ALZHEIMER'S DISEASE, IMMUNOGLOBULIN, IMMUNOTHERAPY, AMYLOID BETA, IMMUNE SYSTEM
1m05:B (ILE35) to (LYS94) HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT | MHC CLASS I, HLA B8, EPSTEIN BARR VIRUS, IMMUNE SYSTEM
1m05:D (ILE35) to (LYS94) HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT | MHC CLASS I, HLA B8, EPSTEIN BARR VIRUS, IMMUNE SYSTEM
1m06:G (TYR94) to (THR174) STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY, X-RAY CRYSTALLOGRAPHY | BACTERIOPHAGE, THREE-DIMENSIONAL STRUCTURE, VIRION, MORPHOGENESIS, PHIX174, ASSEMBLY, MICROVIRIDAE, ICOSAHEDRAL VIRUS, VIRUS-DNA COMPLEX
4olz:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54W IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54W, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4om0:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54Y IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54Y, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5csz:H (PRO162) to (PRO226) CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 | ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM
5csz:A (PRO162) to (PRO226) CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 | ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM
1xr8:B (ASP34) to (LYS94) CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM
1m6o:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE | MHC I, GLYCOPROTEIN, SIGNAL, IMMUNE SYSTEM
5cws:H (PRO185) to (PRO249) CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE | NUCLEOCYTOPLASMIC TRANSPORT, PROTEIN TRANSPORT
4oqt:H (PRO154) to (PRO218) LINGO-1/LI81 FAB COMPLEX | LEUCINE RICH REPEAT, IG DOMAIN, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
2zmw:B (VAL140) to (ALA216) CRYSTAL STRUCTURE OF MONOMERIC KUSABIRA-ORANGE (MKO), ORANGE-EMITTING GFP-LIKE PROTEIN, AT PH 6.0 | GFP-LIKE PROTEIN, LUMINESCENT PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2zmw:D (VAL140) to (ALA216) CRYSTAL STRUCTURE OF MONOMERIC KUSABIRA-ORANGE (MKO), ORANGE-EMITTING GFP-LIKE PROTEIN, AT PH 6.0 | GFP-LIKE PROTEIN, LUMINESCENT PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2zok:H (ILE35) to (TYR94) CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510 | IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE
1xz0:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE | BETA SHEET PLATFORM, MHC-FOLD, PROTEIN-LIPOPEPTIDE COMPLEX, IMMUNE SYSTEM
1xz0:D (ILE35) to (ARG97) CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE | BETA SHEET PLATFORM, MHC-FOLD, PROTEIN-LIPOPEPTIDE COMPLEX, IMMUNE SYSTEM
4ov5:E (SER126) to (ARG189) STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET | IG-LIKE DOMAIN, IMMUNE SYSTEM
4ov5:G (VAL117) to (GLU179) STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET | IG-LIKE DOMAIN, IMMUNE SYSTEM
1y0l:H (PRO151) to (PRO227) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y0l:B (PRO151) to (PRO227) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1y0l:F (PRO151) to (PRO227) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
2zsw:H (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:F (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:D (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
4acp:A (ASP376) to (LEU443) DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT | IMMUNE SYSTEM, IGG, ANTIBODY, KIFUNENSINE
1mcp:H (GLY157) to (ASN221) PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS | IMMUNOGLOBULIN
4acq:A (LYS491) to (ASP559) ALPHA-2 MACROGLOBULIN | HYDROLASE INHIBITOR, PROTEINASE INHIBITOR, IRREVERSIBLE PROTEINASE INHIBITOR, CONFORMATIONAL CHANGE, BLOOD PLASMA INHIBITOR
4acq:B (LYS491) to (ASP559) ALPHA-2 MACROGLOBULIN | HYDROLASE INHIBITOR, PROTEINASE INHIBITOR, IRREVERSIBLE PROTEINASE INHIBITOR, CONFORMATIONAL CHANGE, BLOOD PLASMA INHIBITOR
4acq:C (LYS491) to (ASP559) ALPHA-2 MACROGLOBULIN | HYDROLASE INHIBITOR, PROTEINASE INHIBITOR, IRREVERSIBLE PROTEINASE INHIBITOR, CONFORMATIONAL CHANGE, BLOOD PLASMA INHIBITOR
4acq:D (LYS491) to (ASP559) ALPHA-2 MACROGLOBULIN | HYDROLASE INHIBITOR, PROTEINASE INHIBITOR, IRREVERSIBLE PROTEINASE INHIBITOR, CONFORMATIONAL CHANGE, BLOOD PLASMA INHIBITOR
3kla:B (ILE35) to (LYS94) CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR | MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3kla:E (ILE35) to (LYS94) CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR | MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4ozg:D (GLN126) to (ALA190) D2 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4ozh:D (GLN126) to (ALA190) S16 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4ozi:B (GLN126) to (ARG189) S2 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4ozi:D (ILE127) to (ALA190) S2 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
1mi5:B (ASP34) to (LYS94) THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX | T CELL RECEPTOR, MAJOR HISTOCOMPATABILITY COMPLEX (CLASS I), HLA B8, EPSTEIN BARR VIRUS, IMMUNODOMINANT TCR (LC13), IMMUNE SYSTEM
4aei:I (PRO156) to (PRO219) CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX | IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL
5d1z:B (PRO158) to (PRO222) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d1z:D (PRO164) to (PRO228) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d1z:F (PRO164) to (PRO228) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d1z:G (PRO158) to (PRO222) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
5d2l:B (ILE35) to (ARG97) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2l:J (HIS154) to (ALA237) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2l:H (ASP34) to (ASP96) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2l:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2n:L (ILE35) to (LYS94) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
5d2n:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
4p2r:B (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2r:G (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2r:L (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2r:Q (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2r:T (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p42:A (SER528) to (PRO591) EXTENDED-SYNAPTOTAGMIN 2, SMP - C2A - C2B DOMAINS | ENDOCYTOSIS, SIGNAL TRANSDUCTION, MEMBRANE CONTACT SITE, LIPID BINDING
4p42:B (VAL533) to (PRO591) EXTENDED-SYNAPTOTAGMIN 2, SMP - C2A - C2B DOMAINS | ENDOCYTOSIS, SIGNAL TRANSDUCTION, MEMBRANE CONTACT SITE, LIPID BINDING
4p57:B (SER124) to (GLN189) MHC TCR PEPTIDE COMPLEX | MHC TCR PEPTIDE BE2+ COMPLEX, BERYLLIOSIS, IMMUNE SYSTEM
4p57:D (SER124) to (LYS187) MHC TCR PEPTIDE COMPLEX | MHC TCR PEPTIDE BE2+ COMPLEX, BERYLLIOSIS, IMMUNE SYSTEM
4p5m:H (SER124) to (LYS187) STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY | CBD, AUTOIMMUNITY, BERYLLIUM, IMMUNE SYSTEM
4p5t:D (LYS127) to (ARG190) 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE | MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM
35c8:H (PRO151) to (VAL226) CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
3kpr:B (ASP34) to (HIS84) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
3kpr:E (HIS157) to (ASP247) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
3kpr:G (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
3kpr:J (HIS157) to (ASP247) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
3kps:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
5d4q:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF GASDALIE IGG1 FC | ADCC, IGG FC, IMMUNE SYSTEM
5d5m:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR | ANTIGEN, IMMUNE SYSTEM
5d5m:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR | ANTIGEN, IMMUNE SYSTEM
5d72:L (GLY142) to (PRO208) CRYSTAL STRUCTURE OF MOR04252, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
5d7i:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR | ANTIGEN, RECEPTOR, IMMUNE SYSTEM
5d7i:D (ASP34) to (TRP95) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR | ANTIGEN, RECEPTOR, IMMUNE SYSTEM
5d7j:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
5d7j:F (ILE35) to (ARG97) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
5d7l:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
5d7l:F (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
1yec:H (PRO149) to (PRO223) STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3) | CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE
1yeg:H (PRO149) to (PRO223) STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT | CATALYTIC ANTIBODY
1yei:H (PRO149) to (PRO223) CATALYTIC ANTIBODY D2.3 COMPLEX | CATALYTIC ANTIBODY D2.3 COMPLEX, IMMUNE SYSTEM
1yek:H (PRO149) to (PRO223) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, REACTION PRODUCT, IMMUNE SYSTEM
5d8j:H (PRO155) to (LYS215) DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES. | AP2, FABP4, DIABETES, METABOLIC SYNDROME, IMMUNE SYSTEM
5d93:F (PRO151) to (PRO215) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY | ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE
5d96:J (PRO154) to (PRO217) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1 | ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM
5d96:C (PRO154) to (PRO217) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1 | ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM
1mwa:L (HIS34) to (TYR94) 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX | IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM
1mwa:M (ILE35) to (TRP95) 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX | IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM
5d9s:B (ILE35) to (LYS94) STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V | PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM
3kww:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE | MHC-PEPTIDE, HLA, DISULFIDE BOND, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1ymm:B (SER126) to (ARG189) TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX | PROTEIN-PROTEIN COMPLEX, T CELL REPERTOIRE, AUTO-IMMUNITY, IMMUNE SYSTEM
5dd5:H (PRO149) to (ILE213) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3kym:L (PRO155) to (ARG219) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:N (PRO155) to (THR216) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kyo:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM
3kyo:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM
5ddh:B (ILE35) to (LYS94) STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K | MHC, IMMUNE SYSTEM, PEPTIDE-PROTEIN COMPLEX
5deg:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE | IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2706
4pgb:B (HIS34) to (TYR94) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE
4pgb:E (HIS34) to (TYR94) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE
4pgc:B (HIS34) to (TYR94) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
4pgc:E (HIS34) to (TYR94) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
3l17:A (PHE382) to (LEU467) DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT, SELECTIVE, AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER | KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, TRANSFERASE, PI3K-GAMMA P110 GAMMA
1yq2:A (VAL640) to (ALA717) BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) | GLYCOSYL HYDROLASE FAMILY 2; TIM BARREL; HEXAMER
1yq2:B (VAL640) to (ALA717) BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) | GLYCOSYL HYDROLASE FAMILY 2; TIM BARREL; HEXAMER
1yq2:C (VAL640) to (ALA717) BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) | GLYCOSYL HYDROLASE FAMILY 2; TIM BARREL; HEXAMER
1yq2:D (VAL640) to (ALA717) BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) | GLYCOSYL HYDROLASE FAMILY 2; TIM BARREL; HEXAMER
1yq2:F (VAL640) to (ASP714) BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) | GLYCOSYL HYDROLASE FAMILY 2; TIM BARREL; HEXAMER
3l3j:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
3l3k:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
4pj7:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pj7:C (GLU209) to (GLN268) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pj7:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pj8:B (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjb:B (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjb:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjc:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjc:D (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjd:B (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjd:D (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pje:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pje:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pje:H (HIS153) to (ALA242) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjf:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjf:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjf:F (HIS154) to (GLY241) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjg:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjg:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjh:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjh:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pji:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pji:D (ASP34) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
1yuh:H (PRO154) to (PRO217) FAB FRAGMENT | ANTI-NITROPHENOL, LAMBDA LIGHT CHAIN, IMMUNOGLOBULIN, IMMUNE SYSTEM
5dj2:A (ASP376) to (LEU443) FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
4pjx:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjx:D (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
5dja:A (ASP376) to (LEU443) FC HETERODIMER DESIGN 9.1 Y407M + T366I | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
5dk3:B (PRO156) to (ASP215) CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY | CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM
5dk3:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY | CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM
5dk2:A (ASP376) to (LEU443) FC HETERODIMER E356K/D399K + K392D/K409D | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
3l5w:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l5x:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3agv:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX | IGG, RNA APTAMER, IMMUNE SYSTEM-RNA COMPLEX
1yyl:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3l7e:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5dmg:E (PRO1035) to (PRO1099) X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430) | ANTIBODY, FAB FRAGMENT, TAU PROTEIN, TAU-PSER422, TAU-PSER422 COMPLEX, IMMUNE SYSTEM
5dmi:H (PRO151) to (PRO227) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB | CELL SURFACE RECEPTOR, ANTIBODY-ANTIGEN COMPLEX, ANTITUMOR, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5dmk:B (LYS129) to (ARG192) CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14 | CHROMOGRANIN A, TYPE I DIABETES, T CELL, FUSION PROTEIN, IMMUNE SYSTEM
5dmk:D (LYS129) to (ARG192) CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14 | CHROMOGRANIN A, TYPE I DIABETES, T CELL, FUSION PROTEIN, IMMUNE SYSTEM
3l95:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY | NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM
4pp1:D (PRO156) to (PRO219) THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8 | ALLERGEN, ANTIBODY, IMMUNE SYSTEM
4pp1:F (PRO156) to (ILE217) THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8 | ALLERGEN, ANTIBODY, IMMUNE SYSTEM
4pp2:D (PRO158) to (PRO221) THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9 | ALLERGEN, ANTIBODY, IMMUNE SYSTEM
1z5l:B (ILE35) to (TYR94) STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D | IG FOLD, MHC FOLD, IMMUNE SYSTEM
1z5l:D (HIS34) to (TYR94) STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D | IG FOLD, MHC FOLD, IMMUNE SYSTEM
4pr5:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, STRUCTURAL BIOLOGY, IMMUNE SYSTEM
4pra:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4pre:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4pri:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4pri:E (HIS164) to (TRP250) CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4prn:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4ps4:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4ptu:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 WITH RHAMNOSE | ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM
4pub:H (PRO158) to (PRO222) CRYSTAL STRUCTURE OF FAB DX-2930 | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN-MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, IMMUNE SYSTEM
3am8:C (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX | HUMAN LEUKOCYTE ANTIGEN E, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE SYSTEM
3am8:D (ILE35) to (ARG97) CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX | HUMAN LEUKOCYTE ANTIGEN E, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE SYSTEM
4anv:A (LEU379) to (LEU467) COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. | TRANSFERASE
4pv8:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX | TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM
4pv8:D (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX | TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM
1za6:B (PRO151) to (PRO215) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
1za6:H (PRO151) to (GLU214) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
4pv9:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX | TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM
4pv9:D (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX | TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM
1zan:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5drx:H (PRO162) to (PRO226) CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240 | IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX
5drx:A (PRO162) to (PRO226) CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240 | IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX
5drz:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE | IGG, VIRAL PROTEIN, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
5drz:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE | IGG, VIRAL PROTEIN, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
5ds8:H (PRO149) to (PRO210) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU98, EIF5A, IMMUNE SYSTEM
5dsc:A (PRO149) to (PRO210) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM
5dsc:E (PRO149) to (PRO210) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM
1zea:H (PRO149) to (LYS209) STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE | POLYSPECIFICITY, CROSS-REACTIVITY, ANTI-CHOLERA TOXIN, ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, SUBSTITUTION MATRIX, IMMUNE SYSTEM
4py7:I (PRO153) to (PRO217) CRYSTAL STRUCTURE OF FAB 3.1 | IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM
4py7:A (VAL151) to (PRO214) CRYSTAL STRUCTURE OF FAB 3.1 | IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM
1zgl:T (HIS157) to (SER239) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
1zgl:V (HIS157) to (GLY244) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
1zgp:C (MET141) to (GLY219) CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT K70M | RFP, RED, FLUORESCENT PROTEIN, DSRED, DRFP583, CHROMOPHORE, GFP, CORAL, BETA BARREL, BETA CAN, LUMINESCENT PROTEIN
1zgp:D (MET141) to (GLY219) CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT K70M | RFP, RED, FLUORESCENT PROTEIN, DSRED, DRFP583, CHROMOPHORE, GFP, CORAL, BETA BARREL, BETA CAN, LUMINESCENT PROTEIN
4pyg:A (CYS620) to (PRO686) TRANSGLUTAMINASE2 COMPLEXED WITH GTP | PROTEIN-GTP COMPLEX, TRANSGLUTAMINASE FOLD, CROSSLINKING, GTP BINDING, NO MODIFICATION, TRANSFERASE
3lkn:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5dup:H (PRO163) to (LYS224) INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY AVFLUIGG03 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
3lko:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3lkp:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1zhl:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY | T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM
3lkr:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1zhn:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE | MHC FOLD; ANTIGEN BINDING DOMAIN; IG FOLD, IMMUNE SYSTEM, MEMBRANE PROTEIN
5dur:D (THR151) to (PRO214) INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
5dvo:B (ILE377) to (SER442) FC K392D/K409D HOMODIMER | HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM
3ln4:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM
3ln5:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM
1zlv:H (PRO151) to (PRO227) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlv:M (PRO151) to (PRO227) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
5e08:H (PRO163) to (PRO227) SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT | ANTIBODY, FAB, SSRNA, IMMUNE SYSTEM-RNA COMPLEX
3ls4:H (PRO153) to (PRO216) CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC | IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX
1zsd:B (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX I, B35, B*3501, BULGED PEPTIDE, IMMUNE SYSTEM
3apd:A (LEU379) to (LEU467) CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134 | PHOSPHOINOSITIDE 3-KINASE GAMMA, KINASE, TRANSFERASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
5e2t:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB | IMMUNE SYSTEM
5e2w:H (PRO149) to (PRO213) ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE | IMMUNE SYSTEM
4q6y:A (ILE377) to (LEU443) CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC) | IMMUNE SYSTEM
3ard:B (HIS34) to (TYR94) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA- GALACTOSYLCERAMIDE | MOUSE CD1D, MOUSE NKT TCR, IMMUNE SYSTEM
3are:C (GLN147) to (PRO207) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA- GALACTOSYLCERAMIDE | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3are:D (HIS157) to (ALA246) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA- GALACTOSYLCERAMIDE | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3arg:C (GLN147) to (SER206) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2) | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3lv3:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, SECRETED, CALCIUM CHANNEL, VOLTAGE-GATED CHANNEL
5e6i:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2 | IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX
5e6i:U (ASP34) to (ARG97) CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2 | IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX
4q74:B (ASP376) to (LEU443) F241A FC | IMMUNE SYSTEM
3au1:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3 | IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTING MOLECULE, T-CELL RECEPTOR, CELL SURFACE PROTEIN WITH A SINGLE TRANSMEMBRANE DOMAIN, IMMUNE SYSTEM
5e80:B (GLU72) to (VAL150) THE CRYSTAL STRUCTURE OF PDED IN COMPLEX WITH INHIBITOR-2A | PRENYL BINDING PROTEIN /INHIBITOR, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, GDI-LIKE SOLUBILIZING FACTOR, LIPID BINDING PROTEIN
5e80:A (GLU72) to (VAL150) THE CRYSTAL STRUCTURE OF PDED IN COMPLEX WITH INHIBITOR-2A | PRENYL BINDING PROTEIN /INHIBITOR, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, GDI-LIKE SOLUBILIZING FACTOR, LIPID BINDING PROTEIN
5e94:B (PRO159) to (SER223) ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN | ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN
4q9q:H (PRO161) to (PRO225) CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO BROMO-LIGAND ANALOG IN COMPLEX WITH FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA
5e9d:B (ILE35) to (LYS94) RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2 | SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING
5e9d:G (ILE35) to (LYS94) RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2 | SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING
3m17:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR | IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX
3m1b:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR | IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
3m1b:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR | IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
2a77:H (PRO159) to (PRO222) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II | IMMUNE SYSTEM
3b2u:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2u:C (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2u:J (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2u:N (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2u:T (PRO157) to (PRO221) CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
3b2v:H (PRO157) to (LYS218) CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8 | CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4qhn:B (THR145) to (PRO208) I2 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
5efi:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE | CD1D, LIPOPEPTIDE, ALPHA-HELICAL PEPTIDE, IMMUNE SYSTEM
2a83:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX),HLA-B*2705
3ma7:D (ILE35) to (TYR94) CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D | GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY
3ma7:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D | GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY
3mbe:B (LYS126) to (SER189) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
3mbe:F (LYS126) to (SER189) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
3mbe:H (HIS167) to (ALA252) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
3mbx:H (PRO157) to (PRO221) CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3mck:H (PRO159) to (PRO222) CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3b6s:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SISTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4qok:B (ILE35) to (ARG97) STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM
3mgo:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgo:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgo:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgo:K (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:K (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
5enw:B (ILE35) to (LYS94) STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L | PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM
5eoq:H (PRO158) to (PRO221) STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40 | ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5epm:A (PRO155) to (LYS215) CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT | CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX
3ml8:A (LEU379) to (LEU467) DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN | PHOSPHOINOSITIDE KINASE, INHIBITION, TRANSFERASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
3bes:R (ASP141) to (PRO200) STRUCTURE OF A POXVIRUS IFNGBP/IFNG COMPLEX | ECTROMELIA VIRUS, ORTHOPOXVIRUS, INTERFERON, PROTEIN COMPLEX, ANTIVIRAL DEFENSE, CYTOKINE, GLYCOPROTEIN, RECEPTOR, IMMUNE SYSTEM
3mlw:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlz:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4qrp:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
4qrr:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR, CLONE 12 TCR | HLA B*3501, HUAMN CMV, TCR, T CELL, IMMUNE SYSTEM
4bff:C (HIS47) to (GLU119) SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM ARCHAEOGLOBUS FULGIDUS IN THE REDUCED FORM | OXIDOREDUCTASE, OXYGEN DETOXIFICATION
3mnv:B (PRO151) to (PRO225) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT | HIV-1, HIV, GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mo1:B (PRO151) to (PRO225) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT | HIV-1, HIV, GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3moa:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mob:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3bgm:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, KINASE, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, IMMUNE SYSTEM
5esv:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256. | HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM
5esv:C (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256. | HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM
3bh8:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM
4qth:A (PRO158) to (PRO221) CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12 | ANTIBODY, IMMUNE SYSTEM
5eu3:B (ILE35) to (LYS94) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu4:B (ILE35) to (ARG97) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu4:E (ILE35) to (LYS94) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu5:B (ILE35) to (LYS94) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu7:E (PRO166) to (PRO230) CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB | INTEGRASE, FAB, HIV, VIRAL PROTEIN
5eu7:F (PRO166) to (PRO230) CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB | INTEGRASE, FAB, HIV, VIRAL PROTEIN
5euo:C (GLU212) to (TRP274) PF6-M1-HLA-A2 | TCR, FLU, MHC, IMMUNE SYSTEM
5euo:H (HIS150) to (GLY237) PF6-M1-HLA-A2 | TCR, FLU, MHC, IMMUNE SYSTEM
3mr9:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mrb:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mrd:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mre:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, EPSTEIN-BARR VIRUS, BMLF1 PROTEIN, EB2 PROTEIN
3mrf:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, EPSTEIN-BARR VIRUS, BMLF1 PROTEIN, EB2 PROTEIN
3mrg:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrh:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mri:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrj:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrk:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, TUMORAL PEPTIDE, ALPHA-FETOPROTEIN
3mrl:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrm:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrn:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS4B PROTEIN
3mrp:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1
3mrq:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1
3mrr:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, PROSTAGLANDIN TRANSPORTER, TUMORAL PEPTIDE, MELAN-A ANALOGUE, MART1 ANALOGUE, SELF PEPTIDE
5ewi:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 | FAB, HIV-1, V1V2, ENV, ANTIBODY, ENVELOPE, NEUTRALIZING, IMMUNE SYSTEM
5exb:H (LEU137) to (ALA215) WILD TYPE GREEN FLUORESCENT PROTEIN DENDFP (DENDRONEPHTHYA SP.) | FLUORESCENT PROTEIN, PHOTOSWITCHABLE FLUORESCENT PROTEINS, CHROMOPHORE, BETA-BARREL, BIOMARKER
3bkj:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
3bkm:H (PRO149) to (PRO212) STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
3muu:A (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
3muu:B (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
3muu:C (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
3muu:D (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
3muu:E (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
3muu:F (ILE83) to (ARG128) CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH | BETA BARRELS, IG-LIKE FOLDS, VIRAL PROTEIN
4bm7:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION | IMMUNE SYSTEM, GLYCAN
4bm7:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION | IMMUNE SYSTEM, GLYCAN
3bn9:D (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2 | ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE
3bo8:B (ASP34) to (LYS94) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE | MELANOMA ASSOCIATED ANTIGEN, MAGE, MAGE-A1, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-A1, HLA-A010101, TCR, T-CELL RECEPTOR, ANTIBODY, FAB-HYB3, HYB3, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MHC I, SULFATION, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, TUMOR ANTIGEN, IMMUNE SYSTEM
3bp4:B (ILE35) to (LYS94) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM
5f1i:E (ILE35) to (LYS94) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:H (ASP34) to (LYS94) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:K (ILE35) to (ARG97) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:N (ILE35) to (LYS94) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:Q (ILE35) to (ARG97) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:T (ILE35) to (LYS94) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
5f1i:W (ILE35) to (LYS94) MHC WITH 9-MER PEPTIDE | MHC, IMMUNE SYSTEM
3mv7:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG | HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM
3mv9:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG | HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM
3mxw:H (PRO149) to (PRO213) CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT | ANTIBODY COMPLEX, FAB FRAGMENT, METALLOPROTEASE, CALCIUM BINDING, ZINC HYDROLASE, DEVELOPMENT, MORPHOGEN, SIGNALING PROTEIN
3myj:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT. | WT-1 PEPTIDE, R1Y MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5f88:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3bvn:B (ASP34) to (LYS94) HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM
3bvn:E (ILE35) to (LYS94) HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM
3mzt:A (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
3mzt:B (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
3mzt:C (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
3mzt:D (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
3mzt:E (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
3mzt:F (ILE35) to (ASP96) PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | THIOFLAVIN T, AMYLOID, PARKINSON'S, ALZHEIMER'S, IMMUNE SYSTEM
4bsk:A (PRO56) to (ARG133) CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH VEGFR-3 DOMAINS D1-2 | TRANSFERASE-HORMONE COMPLEX, TRANSFERASE, LYMPHANGIOGENESIS, ANGIOGENESIS, IG DOMAIN, GLYCOPROTEIN, RECEPTOR TYROSINE KINASE, DIMERIZATION
4bsk:A (ASN166) to (HIS223) CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH VEGFR-3 DOMAINS D1-2 | TRANSFERASE-HORMONE COMPLEX, TRANSFERASE, LYMPHANGIOGENESIS, ANGIOGENESIS, IG DOMAIN, GLYCOPROTEIN, RECEPTOR TYROSINE KINASE, DIMERIZATION
5f96:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1, ANTIBODY, CH235 LINEAGE, VH1-46 GERMLINE, IMMUNE SYSTEM
3bw9:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN | HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3bxn:B (ILE35) to (LYS94) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEOKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*1402, HLA-B1402, HLA-B*14, PCATA, CATHEPSIN A, ANKYLOSING SPONDYLITIS, AUTOIMMUNITY, IMMUNE SYSTEM
5f9o:H (PRO158) to (PRO222) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | ANTIBODY EVOLUTION HIV-1 BROADLY NEUTRALIZING CD4 BINDING SITE, IMMUNE SYSTEM
3bze:B (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- E | MHC FOLD, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3bze:D (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- E | MHC FOLD, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3bze:F (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- E | MHC FOLD, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5ff6:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4r4b:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C | IGG, FAB, HIV, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4r4b:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C | IGG, FAB, HIV, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4r4b:D (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C | IGG, FAB, HIV, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5fgc:E (PRO163) to (PRO227) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, VIRAL PROTEIN
3c5s:D (PRO151) to (PRO214) CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG | ANTIBODY, O-ANTIGEN, LPS, SHIGELLA FLEXNERI, IMMUNE SYSTEM
3c5z:H (LYS153) to (ALA217) CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506 | TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
3c60:D (LYS153) to (LYS216) CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62 | TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN/IMMUNE SYSTEM COMPLEX
3c60:H (LYS153) to (LYS216) CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62 | TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN/IMMUNE SYSTEM COMPLEX
4r7d:E (PRO154) to (PRO218) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:O (PRO154) to (PRO218) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4bz1:H (PRO153) to (LYS213) STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, FUSION LOOP, VIRION
3c9n:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HLA-B*1501, SARS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3na9:H (PRO149) to (ARG210) CRYSTAL STRUCTURE OF FAB15 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3nab:H (PRO149) to (SER213) CRYSTAL STRUCTURE OF FAB15 MUT6 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3nac:H (PRO149) to (ARG210) CRYSTAL STRUCTURE OF FAB15 MUT7 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
4r96:B (PRO155) to (PRO219) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r96:D (PRO155) to (PRO219) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r96:F (PRO155) to (PRO219) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r96:H (PRO155) to (PRO219) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r9h:A (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT AT 1.9 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4r9h:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT AT 1.9 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4r9h:C (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT AT 1.9 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4r9h:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT AT 1.9 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4ra3:A (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT IN COMPLEX WITH THIOFLAVIN (THT) AT 2.8 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, THIOFLAVIN, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4ra3:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT IN COMPLEX WITH THIOFLAVIN (THT) AT 2.8 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, THIOFLAVIN, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4ra3:C (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT IN COMPLEX WITH THIOFLAVIN (THT) AT 2.8 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, THIOFLAVIN, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4ra3:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT IN COMPLEX WITH THIOFLAVIN (THT) AT 2.8 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, THIOFLAVIN, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
4rah:A (ILE35) to (LYS94) CRYSTAL STRUCTURE OF DIMERIC S33C BETA-2 MICROGLOBULIN MUTANT AT 1.4 ANGSTROM RESOLUTION | AMYLOIDOSIS, PROTEIN AGGREGATION, COVALENT DIMER, OLIGOMERIZATION, BETA SANDWICH, INCLUSION BODIES, IMMUNE SYSTEM
5fji:A (GLY780) to (PRO858) THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES | HYDROLASE, N-GLYCOSYLATION, GLUCOSIDASE,
5fji:B (GLY780) to (PRO858) THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES | HYDROLASE, N-GLYCOSYLATION, GLUCOSIDASE,
3cdg:B (ILE35) to (LYS94) HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E | NK CELL RECEPTOR, IMMUNITY, C-TYPE LECTIN, MHC, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, SIGNAL-ANCHOR, IMMUNE SYSTEM
3cdg:D (ILE35) to (LYS94) HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E | NK CELL RECEPTOR, IMMUNITY, C-TYPE LECTIN, MHC, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, SIGNAL-ANCHOR, IMMUNE SYSTEM
4rbp:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
4rbp:M (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
3ncj:H (PRO149) to (ARG210) CRYSTAL STRUCTURE OF FAB15 MUT8 | ANTIBODY, IMMUNE SYSTEM
3cfj:B (PRO151) to (PRO227) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3cfj:D (PRO151) to (PRO227) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3nfp:H (VAL153) to (PRO216) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
4rfn:B (GLU148) to (GLU212) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4rfo:H (PRO149) to (GLU212) CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 | HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
3ngb:J (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4rgm:H (PRO157) to (PRO220) STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1 | NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX
4rgm:C (PRO157) to (PRO220) STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1 | NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX
3cii:A (GLU212) to (TRP274) STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E | C-TYPE LECTIN-LIKE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, LECTIN, RECEPTOR, SIGNAL- ANCHOR, IMMUNE SYSTEM
3cii:B (ILE35) to (LYS94) STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E | C-TYPE LECTIN-LIKE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, LECTIN, RECEPTOR, SIGNAL- ANCHOR, IMMUNE SYSTEM
3cii:D (GLU212) to (TRP274) STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E | C-TYPE LECTIN-LIKE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, LECTIN, RECEPTOR, SIGNAL- ANCHOR, IMMUNE SYSTEM
3cii:E (ILE35) to (LYS94) STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E | C-TYPE LECTIN-LIKE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, LECTIN, RECEPTOR, SIGNAL- ANCHOR, IMMUNE SYSTEM
3nh7:H (PRO156) to (PRO220) CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA | ANTIBODY-ANTIGEN COMPLEX, BMP RECEPTOR EXTRACELLULAR DOMAIN, BONE MORPHOGENETIC PROTEIN, IMMUNE SYSTEM
3ciq:A (ILE35) to (ARG97) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:B (ILE35) to (ARG97) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:C (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:D (ILE35) to (ARG97) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:E (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:F (ILE35) to (ARG97) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:G (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:I (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:J (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:K (ILE35) to (ARG97) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ciq:L (ILE35) to (LYS94) A REGULATABLE SWITCH MEDIATES SELF-ASSOCIATION IN AN IMMUNOGLOBULIN FOLD | CLASS-1 MHC, AMYLOID, PROTEIN FOLDING, DIALYSIS-RELATED AMYLOIDOSIS, BETA-2 MICROGLOBULIN, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4c4u:L (HIS47) to (GLU119) SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM ARCHAEOGLOBUS FULGIDUS E12Q MUTANT IN THE REDUCED FORM | OXIDOREDUCTASE, OXYGEN DETOXIFICATION
3nid:E (PRO155) to (LYS215) THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX
3nif:E (PRO155) to (LYS215) THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX
3nig:H (PRO155) to (LYS215) THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-IMMUNE SYSTEM COMPLEX, CELL ADHESION-BLOOD CLOTTING COMPLEX
4c56:E (SER126) to (ALA190) X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B, T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II | IMMUNE SYSTEM-TOXIN COMPLEX
4c56:K (SER126) to (ARG189) X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B, T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II | IMMUNE SYSTEM-TOXIN COMPLEX
3cle:H (PRO149) to (PRO223) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3clf:H (VAL150) to (PRO223) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4c7w:B (THR229) to (PRO286) CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ-ESTERASE IN COMPLEX WITH 4-O-ACETYLATED SIALIC ACID | HYDROLASE, RECEPTOR DESTROYING, RECEPTOR BINDING
4c83:C (PRO149) to (ILE210) CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS | IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX
4cad:B (PRO161) to (PRO224) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:E (PRO161) to (PRO224) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:H (PRO161) to (LYS221) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:K (PRO161) to (PRO224) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cc8:F (PRO149) to (PRO213) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:H (PRO149) to (PRO213) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:I (PRO149) to (PRO213) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
3ntc:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF KD-247 FAB, AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY | KD-247, HUMANIZED ANTIBODY, ANTI-V3, FAB, IMMUNE SYSTEM
4rrp:K (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
4rrp:L (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
3csf:A (THR377) to (LEU467) CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2 | PHOSPHOINOSITIDE 3-KINASE GAMMA, PI3K, TRANSFERASE
3csy:A (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:E (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:G (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3nwm:A (HIS34) to (TYR94) CRYSTAL STRUCTURE OF A SINGLE CHAIN CONSTRUCT COMPOSED OF MHC CLASS I H-2KD, BETA-2MICROGLOBULIN AND A PEPTIDE WHICH IS AN AUTOANTIGEN FOR TYPE 1 DIABETES | MHC CLASS I, H-2KD, PEPTIDE-MHC COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3cup:B (ILE127) to (TRP188) CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235 | HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, IMMUNE SYSTEM
3cvh:N (ILE35) to (TYR94) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3o11:B (PRO155) to (PRO219) ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3o2w:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG | IGG ANTIBODY FAB, IMMUNE SYSTEM
4rx4:A (PRO149) to (GLU212) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3czf:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2709
3o4l:B (ILE35) to (LYS94) GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS | MHC I, IMMUNOGLOBULIN, ANTIGEN PRESENTATION, IMMUNE RECOGNITION, IMMUNE SYSTEM
3o4l:E (HIS156) to (TRP242) GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS | MHC I, IMMUNOGLOBULIN, ANTIGEN PRESENTATION, IMMUNE RECOGNITION, IMMUNE SYSTEM
3o6f:B (SER155) to (ARG218) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3o6f:F (SER155) to (ARG218) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3o6f:H (HIS154) to (TRP240) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3d0v:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW | 2F5, HIV, GP41, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
4s1d:O (PRO156) to (PRO219) STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE | ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM
4s1s:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H5.F-185917, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
3d25:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC, HLA-A2, SECONDARY ANCHOR RESIDUE, GLYCOPROTEIN, IMMUNE SYSTEM, MINOR HISTOCOMPATIBILITY ANTIGEN, STEM CELL TRANSPLANTATION, IMMUNE RESPONSE
3d3v:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE | HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM
3d3v:D (GLN147) to (SER206) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE | HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM
3o8x:B (ILE35) to (TYR94) RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4s2s:A (PRO155) to (PRO218) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3o9w:B (ILE35) to (ARG97) RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3oay:M (PRO151) to (PRO227) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oay:H (PRO151) to (PRO227) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:H (PRO151) to (PRO227) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:M (PRO151) to (PRO227) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3d85:B (PRO151) to (PRO215) CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB | INTERLEUKIN-23, FAB, IMMUNE SYSTEM/CYTOKINE COMPLEX
3d85:D (ASP129) to (PHE205) CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB | INTERLEUKIN-23, FAB, IMMUNE SYSTEM/CYTOKINE COMPLEX
3d9a:H (PRO449) to (ILE510) HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME | LYSOZYME, HYHEL10, FAB, ANTIBODY, ANTIGEN, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4cvz:B (ILE34) to (LYS93) COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE | IMMUNE SYSTEM, MHC, B21
4cw1:B (ILE34) to (LYS93) COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE | IMMUNE SYSTEM, MHC, B14
4cw1:E (LYS33) to (LYS93) COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE | IMMUNE SYSTEM, MHC, B14
4tnw:K (GLY145) to (SER210) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3dbx:B (ILE35) to (TRP95) STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID | CD1, EVOLUTION, ANTIGEN-PRESENTATION, MHC-FOLD, HYDROPHOBIC BINDING GROOVE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5ggq:H (PRO149) to (LYS209) CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT | THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
5ggr:H (PRO149) to (PRO213) PD-1 IN COMPLEX WITH NIVOLUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggs:A (PRO156) to (PRO220) PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggs:C (PRO156) to (PRO220) PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggu:A (PRO161) to (PRO225) CRYSTAL STRUCTURE OF TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggv:H (PRO161) to (PRO225) CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
4d0b:A (PRO208) to (SER269) COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE | IMMUNE SYSTEM
5ghw:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND | BROAD NEUTRALIZING ANTIBODY, RECOMBINANT FAB, EPITOPE, IMMUNE SYSTEM, HIV-1, VIRAL MEMBRANE
4tsb:L (THR145) to (ALA207) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
5gis:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE | FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM
3dif:D (PRO155) to (PRO218) CRYSTAL STRUCTURE OF FABOX117 | ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4tul:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | IMMUNE SYSTEM, NEUROBLASTOMA
4tuo:A (PRO149) to (PRO212) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | NEUROBLASTOMA, IMMUNE SYSTEM
4d3c:H (PRO152) to (SER216) CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68. | PROTEIN BINDING
4d8p:B (GLN126) to (ARG189) STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE | CLASS II MHC, IMMUNE SYSTEM
3dro:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE | HIV-1, GP41, 2F5, NMAB, IMMUNE SYSTEM
4u1h:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1i:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1j:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1l:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1l:E (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1m:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1n:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1s:B (ASP34) to (LYS94) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4d9r:H (PRO157) to (PRO221) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4d9r:E (PRO157) to (PRO221) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4dag:H (PRO158) to (VAL220) STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE | VIRAL PROTEIN, MPV FUSION PROTEIN, ANTIBODY, IMMUNE SYSTEM, DS7 ANTIBODY STRUCTURE, DS7, FAB STRUCTURE, VACCINE, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3dtx:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SYSTEM-COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA- B*2705, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, SECRETED, MHC I, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM
3duh:B (ASP129) to (PHE205) STRUCTURE OF INTERLEUKIN-23 | FOUR-HELIX BUNDLE CYTOKINE, IG DOMAIN, CYTOKINE, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIVIRAL DEFENSE, IMMUNE RESPONSE, INFLAMMATORY RESPONSE, INNATE IMMUNITY, TISSUE REMODELING, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
5hcg:H (PRO280) to (PRO344) CRYSTAL STRUCTURE OF FREE-CODV. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBIN, MULTIFUNCTIONAL BIOTHERAPEUTIC FORMAT, BISPECIFIC PROPERTY, CODV, IMMUNE SYSTEM
3ox8:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
3ox8:E (ILE35) to (HIS84) CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
3oxr:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
3oxs:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
5hga:B (ILE35) to (LYS94) HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hga:E (ILE35) to (LYS94) HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
4dgy:H (PRO149) to (PRO213) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
5hgb:B (ILE35) to (LYS94) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:E (ASP34) to (LYS94) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:H (ILE35) to (LYS94) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:K (ILE35) to (LYS94) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hhn:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hho:E (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhq:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hi4:D (ALA144) to (ALA208) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi4:L (THR146) to (PRO209) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi5:D (ALA144) to (ALA208) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
3p0y:H (PRO149) to (PRO213) ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION | BETA-SANDWICH, ANTIGENS EGFR, IMMUNE SYSTEM
5hj3:E (PRO151) to (LYS221) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5hj3:I (PRO151) to (ASP220) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5hj3:M (PRO151) to (ASP220) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5hj3:A (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4dke:I (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
4u6v:H (PRO158) to (PRO222) MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY | ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM
4u6v:K (PRO158) to (PRO222) MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY | ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM
4dkf:I (PRO149) to (LYS209) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
4u6x:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA, A 15 MER SELF- PEPTIDE | HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM
4u6y:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK, A 15 MER SELF- PEPTIDE | HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM
3p4m:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV | H2-KB, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
3p4m:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV | H2-KB, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
3p4o:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL, AN 8-MER MODIFIED PEPTIDE FROM THE LCMV | H2-KB, LCMV-V3A, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
3p9l:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3p9l:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3p9m:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3p9m:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3pab:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3pab:E (ILE35) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
3pay:B (ALA203) to (ASN268) CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION
3pay:C (ALA203) to (ASN268) CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION
3pay:D (ALA203) to (ASN268) CRYSTAL STRUCTURE OF A PUTATIVE ADHESIN (BACOVA_04077) FROM BACTEROIDES OVATUS AT 2.50 A RESOLUTION | STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION
5hyj:B (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5hyj:G (ILE35) to (LYS94) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5hyq:B (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5i16:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i16:B (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i15:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i17:B (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i19:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1c:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-20 | IMMUNE SYSTEM
5i1d:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1e:H (PRO154) to (PRO218) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1g:H (PRO154) to (PRO218) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1j:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1l:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3pgc:B (SER126) to (ALA190) CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120, FLIPPED PEPTIDE ORIENTATION | MHC CLASS II, MHC II, IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP
3pgc:E (SER126) to (ARG189) CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120, FLIPPED PEPTIDE ORIENTATION | MHC CLASS II, MHC II, IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP
4dvb:H (PRO148) to (VAL211) THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112 | IMMUNE SYSTEM, HYDROLASE
3pnw:B (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:E (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:K (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:N (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:T (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
5i8c:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8h:E (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8h:G (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8k:H (PRO152) to (PRO216) HHH1 FAB FRAGMENT | ANTIBODY, GLYCAN BINDING, FAB, ALLERGY, IMMUNE SYSTEM
5i8o:H (PRO152) to (PRO216) HMM5 FAB IN COMPLEX WITH DISACCHARIDE | ANTIBODY FAB GLYCAN ALLERGY, IMMUNE SYSTEM
5i9q:B (PRO149) to (GLU212) CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
5i9q:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
4uq2:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM
4uq2:D (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM
4uq3:B (ILE36) to (LYS95) CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE
4uq3:D (ILE36) to (LYS95) CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE
3pp3:H (PRO155) to (PRO219) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM
5ibu:G (PRO161) to (PRO225) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
5ibu:H (PRO161) to (PRO225) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
5id1:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4e5x:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX | AD2 E3-19K-HLA-A2 COMPLEX, UNIQUE TERTIARY STRUCTURE, ADENOVIRUS E3- 19K, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, ENDOPLASMIC RETICULUM, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX
4e5x:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX | AD2 E3-19K-HLA-A2 COMPLEX, UNIQUE TERTIARY STRUCTURE, ADENOVIRUS E3- 19K, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, ENDOPLASMIC RETICULUM, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX
5ies:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A | HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
5if0:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A | HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3pqy:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224 | H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM
4uv4:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT | IMMUNE SYSTEM, ANTIBODY ENGINEERING, PHAGE DISPLAY, LONG CDR, FORMYL PEPTIDE RECEPTOR-1
4uv7:H (PRO158) to (PRO222) THE COMPLEX STRUCTURE OF EXTRACELLULAR DOMAIN OF EGFR AND GC1118A | TRANSFERASE, RECEPTOR TYROSINE KINASE, ANTIBODY
3prz:A (LEU379) to (LEU467) QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS. | PHOSPHOINOSITIDE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4eds:B (LEU138) to (VAL218) CRYSTAL STRUCTURE OF FAR-RED FLUORESCENT PROTEIN EQFP670 | BETA BARREL, FLUORESCENT PROTEIN
3pvo:J (PHE33) to (LEU83) MONOCLINIC FORM OF HUMAN C-REACTIVE PROTEIN | PENTRAXIN FAMILY, IMMUNE SYSTEM
4ei5:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1 | SULFATIDE, LIPID, CD1D, NKT TYPEII, TCR, IMMUNE SYSTEM
4ei5:F (HIS34) to (TYR94) CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1 | SULFATIDE, LIPID, CD1D, NKT TYPEII, TCR, IMMUNE SYSTEM
4ei6:B (HIS154) to (ALA243) STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR | NATURAL KILLER T CELL RECEPTOR, IMMUNE SYSTEM
5im7:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9, IMMUNE SYSTEM
5im7:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9, IMMUNE SYSTEM
3pwj:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT | HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwj:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT | HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwl:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwl:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwn:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING
3pwn:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING
3pwp:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwu:B (HIS34) to (TYR94) AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11) | MHC BOLA CONFORMATION, IMMUNODOMINANT EPITOPE CATTLE, IMMUNE SYSTEM
5inc:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_S3T, IMMUNE SYSTEM
5inc:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_S3T, IMMUNE SYSTEM
4en3:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE | IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN PRESENTATION- RECOGNITION, MEMBRANE, IMMUNE SYSTEM
5ir1:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5iro:S (ASP34) to (LYS94) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX | AD4 E3-19K-HLA-A2 COMPLEX, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX
3q5t:A (HIS154) to (TRP236) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
3q5y:A (HIS156) to (ALA245) V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES | IG, T CELL RECEPTOR, ANTIGEN PEPTIDE/MHC, MEMBRANE, IMMUNE SYSTEM
5iv2:B (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT | IMMUNE SYSTEM
4etq:H (PRO156) to (PRO219) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4eup:E (ILE35) to (LYS94) THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE | NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM
4eup:H (HIS153) to (GLY240) THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE | NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM
4eup:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE | NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM
3qaz:U (THR64) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qaz:X (THR64) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qaz:a (THR64) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qaz:d (PRO60) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qaz:g (PRO60) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qaz:j (THR64) to (MET123) IL-2 MUTANT D10 TERNARY COMPLEX | CYTOKINE RECEPTOR SIGNALING COMPLEX, SIGNALING PROTEIN-CYTOKINE COMPLEX
3qct:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
3qcv:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2) | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
4ezj:A (LEU379) to (ILE469) POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF | KINASE P110, P110-GAMMA, LIPID KINASE, CYTOPLASMIC, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
3qdg:B (ILE35) to (LYS94) THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE | MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, CROSS- REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM
3qdj:B (ILE35) to (LYS94) THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3qdm:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3qeh:C (PRO149) to (GLU212) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qeh:E (PRO149) to (GLU212) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qeu:B (HIS155) to (TRP241) THE CRYSTAL STRUCTURE OF TCR DMF5 | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3qfd:B (ASP34) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM
3qfd:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM
4f33:B (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:D (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:F (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
3qfj:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE | TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, Y5F MUTATION, IMMUNE SYSTEM
4f37:F (PRO161) to (LYS221) STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE | AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM
4f37:H (PRO161) to (VAL218) STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE | AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM
5iz5:B (SER41) to (ASP110) HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 | SIGNAL TRANSDUCTION, PHOSPHOLIPASE, ALPHA/BETA HYDROLASE, CALCIUM BINDING, C2 DOMAIN, HYDROLASE
5iz5:A (TYR46) to (SER112) HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 | SIGNAL TRANSDUCTION, PHOSPHOLIPASE, ALPHA/BETA HYDROLASE, CALCIUM BINDING, C2 DOMAIN, HYDROLASE
3qh3:D (HIS155) to (ALA244) THE CRYSTAL STRUCTURE OF TCR A6 | TAX PEPTIDE, TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM
5j3d:A (PRO164) to (PRO228) CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F | ANTIBODY, VIRUS, COMPLEX, IMMUNE SYSTEM
3qib:B (ASN126) to (VAL186) CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK | IG DOMAIN, IMMUNE SYSTEM
3qib:D (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK | IG DOMAIN, IMMUNE SYSTEM
3qiu:B (ASN126) to (VAL186) CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, MHC MOLECULE, IMMUNE SYSTEM
3qiw:B (ASN126) to (VAL186) CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, MHC MOLECULE, IMMUNE SYSTEM
5j6h:B (HIS34) to (TYR94) RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C | IMMUNE SYSTEM
4f7m:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658) | HLA-A*2402, INFLUENZA A VIRUS, 2009 H1N1, HLA-A3 SUPERTYPE, IMMUNE SYSTEM
4f7p:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505) | HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS ALLELE RECOGNITION, IMMUNE SYSTEM
4f7t:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505) | HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM
4fa6:A (THR377) to (LEU467) DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR | PHOSPHOINOSITIDE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3qnx:B (PRO155) to (PRO219) ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qny:B (LEU156) to (PRO221) MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qny:D (LEU156) to (PRO221) MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qnz:B (PRO155) to (PRO219) ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qo0:B (PRO155) to (PRO219) MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4fc3:E (LYS77) to (VAL137) CRYSTAL STRUCTURE OF HUMAN METHAEMOGLOBIN COMPLEXED WITH THE SECOND NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS | GLOBIN FOLD, IG FOLD, OXYGEN TRANSPORT, HAEM ACQUISITION, OXYGEN BINDING, HAEM BINDING, CELL WALL, OXYGEN TRANSPORT-PROTEIN BINDING COMPLEX
3qpq:D (PRO155) to (HIS219) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qpq:J (PRO155) to (HIS218) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qpx:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF FAB C2507 | IMMUNOGLOBULIN, IMMUNE SYSTEM, MOUSE IL-17A
3qux:B (HIS34) to (TYR94) STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4ffz:H (PRO149) to (SER212) CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN). | STRUCTURAL GENOMICS, ANTIBODY FAB FRAGMENT, FLAVIVIRUS, DENGUE VIRUS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNOGLOBULIN-LIKE DOMAIN, VIRAL ENVELOPE PROTEIN, VIRION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4ffz:Z (PRO149) to (SER212) CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN). | STRUCTURAL GENOMICS, ANTIBODY FAB FRAGMENT, FLAVIVIRUS, DENGUE VIRUS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNOGLOBULIN-LIKE DOMAIN, VIRAL ENVELOPE PROTEIN, VIRION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3qwo:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB | IMMUNE COMPLEX, IMMUNE SYSTEM
3qwo:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB | IMMUNE COMPLEX, IMMUNE SYSTEM
3qwr:A (ASP129) to (PHE205) CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH AN ADNECTIN | FOUR-HELIX BUNDLE CYTOKINE, IG DOMAIN, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIVIRAL DEFENSE, IMMUNE RESPONSE, INFLAMMATORY RESPONSE, INNATE IMMUNITY, TISSUE REMODELING, ADNECTIN, ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN BINDING-CYTOKINE COMPLEX
3qzw:B (ILE35) to (LYS94) PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 | IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR
3qzw:E (ILE35) to (LYS94) PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 | IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR
4flh:A (LEU379) to (LEU460) CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511 | P110, PHOSPHOTRANSFERASE, CANCER, P85, PHOSPHORYLATION, TRANSFERASE- INHIBITOR COMPLEX
3r7q:A (THR377) to (LEU467) STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3- KINASE | KINASE P110, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4fnl:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
4fnl:I (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
4fp8:K (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5jil:A (MET224) to (PRO281) CRYSTAL STRUCTURE OF RAT CORONAVIRUS STRAIN NEW-JERSEY HEMAGGLUTININ- ESTERASE IN COMPLEX WITH 4N-ACETYL SIALIC ACID | HEMAGGLUTIN, ESTERASE, HEPATITIS VIRUS, CORONAVIRUS, VIRAL PROTEIN, SIALIC ACID
3rew:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN
3rew:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN
4fq1:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF PGT121 FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
4fq1:L (THR146) to (PRO209) CRYSTAL STRUCTURE OF PGT121 FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
3rgv:D (HIS34) to (TYR94) A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS | TCR, MHC, MHC CLASS I, IMMUNE SYSTEM
4ftv:B (ASP34) to (LYS94) THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE | TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, HIGH AFFINITY, C134, IMMUNE SYSTEM
3ri5:K (THR148) to (SER210) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND PICROTOXIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ri5:O (VAL146) to (SER208) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND PICROTOXIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:K (THR148) to (SER210) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3ria:O (VAL146) to (SER208) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND IODIDE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rif:O (VAL146) to (SER208) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND GLUTAMATE. | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4fz8:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY. | ADCC, ANTI-HIV-1 ENV ANTIBODY C11, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
5jw5:H (PRO164) to (PRO228) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
5jw5:A (PRO164) to (PRO228) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
5jxe:G (PRO156) to (VAL218) HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB | HUMAN PD-1 PEMBROLIZUMAB FAB, IMMUNE SYSTEM
4g42:E (ILE34) to (GLU97) STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D | MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM
4g43:B (ILE34) to (LYS93) STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E | MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM
4g6a:C (PRO149) to (PRO213) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4g6a:H (PRO149) to (PRO213) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4g7v:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g8g:E (HIS166) to (GLY253) CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10 | TCR, T CELL, HLA B*2705, KK10, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
4g9d:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B2705-KK10 | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
4g9f:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
5k9j:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION. | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:H (PRO164) to (PRO228) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
4gb9:A (PHE382) to (ILE469) POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA | KINASE P110 GAMMA-ISOFORM, KINASE, LIPID KINASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
4gbx:B (SER126) to (ARG189) CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5 | IMMUNE COMPLEX, PEPTIDE LOADING, PEPTIDE EDITING, ANTIGEN PRESENTATION, IMMUNE SYSTEM
5kc6:C (THR126) to (PHE188) CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT) | CEREBELLIN, NEUROTRANSMISSION, SIGNALING PROTEIN
4gg6:B (GLN126) to (TRP188) PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4gg6:D (GLN126) to (ARG189) PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4gkn:B (ILE35) to (LYS94) A2-MHC COMPLEX CARRYING FATGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gkn:E (ILE35) to (LYS94) A2-MHC COMPLEX CARRYING FATGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gks:B (ILE35) to (LYS94) A2-MHC COMPLEX CARRYING FLTGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gks:E (ILE35) to (LYS94) A2-MHC COMPLEX CARRYING FLTGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gkz:B (HIS153) to (ALA242) HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II (PMHC-II), T-CELL, T-CELL RECEPTOR (TCR), INFLUENZA, HA1.7, IMMUNE SYSTEM
5ks9:B (GLN126) to (ARG189) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksb:B (GLN126) to (ARG189) T15-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5kvd:H (PRO151) to (PRO227) ZIKA SPECIFIC ANTIBODY, ZV-2, BOUND TO ZIKA ENVELOPE DIII | ZIKA VIRUS, ENVELOPE DIII, VIRAL PROTEIN, ANTIBODY, IGG2C, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5l2j:B (ILE37) to (LYS96) CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM | CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, IMMUNE SYSTEM
5l2k:B (ILE37) to (LYS96) CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX | CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, GEM42, IMMUNE SYSTEM
5l5g:C (SER983) to (SER1031) PLEXIN A2 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 8 MODELED, DATA TO 10 ANGSTROM | RECEPTOR, SIGNALING, AXON GUIDANCE, SIGNALING PROTEIN
5l5g:D (SER983) to (SER1031) PLEXIN A2 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 8 MODELED, DATA TO 10 ANGSTROM | RECEPTOR, SIGNALING, AXON GUIDANCE, SIGNALING PROTEIN
5l8s:D (LEU149) to (ASN192) THE CRYSTAL STRUCTURE OF A COLD-ADAPTED ACYLAMINOACYL PEPTIDASE REVEALS A NOVEL QUATERNARY ARCHITECTURE BASED ON THE ARM-EXCHANGE MECHANISM | ACYL AMINOACYL PEPTIDASE, ALPHA/BETA HYDROLASE DOMAIN, ARM EXCHANGE, BETA-PROPELLER DOMAIN, COLD ADAPTATION, DIMERIZATION, PROLINE HINGE, SPOROSARCINA PSYCHROPHILA, HYDROLASE
5ldr:B (ASP673) to (GLY731) CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN IN COMPLEX WITH GALACTOSE | BETA-D-GALACTOSIDASE, COLD-ADAPTED, DIMERIC, COMPLEX, GALACTOSE, HYDROLASE
5lki:A (ARG1659) to (SER1716) CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE | NANODISC, TOXIN, INJECTION, PORE-FORMING
5lki:B (ARG1659) to (SER1716) CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE | NANODISC, TOXIN, INJECTION, PORE-FORMING
5lki:C (ARG1659) to (SER1716) CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE | NANODISC, TOXIN, INJECTION, PORE-FORMING
5lki:D (ARG1659) to (SER1716) CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE | NANODISC, TOXIN, INJECTION, PORE-FORMING
5lki:E (ARG1659) to (SER1716) CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE | NANODISC, TOXIN, INJECTION, PORE-FORMING
5swq:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231, AN INFLUENZA EPITOPE | HLA-A*02:01, CROSS-REACTIVITY, HETEROLOGOUS IMMUNITY, TCR, T CELL, IMMUNE SYSTEM
5swz:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5swz:G (ILE35) to (TYR94) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5swz:L (ILE35) to (TYR94) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5swz:Q (HIS34) to (ASP96) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5sx5:H (PRO155) to (GLU218) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
5t1k:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5t5n:K (PRO152) to (PRO215) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:M (PRO152) to (PRO215) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5t5n:O (PRO152) to (PRO215) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM | ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN
5te6:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE | HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM
5te7:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE C STRAIN DU172.17 GP120 CORE | HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM
5tfs:H (PRO149) to (PRO213) STRUCTURE OF CHIMERIC 02-K FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, HIV-1, VRC01, CDRH3, CD4-BS, VH1-2, IMMUNE SYSTEM
1n7m:L (PRO150) to (PRO214) GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN | IMMUNE SYSTEM
1a1m:B (ILE35) to (LYS94) MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, HIV, COMPLEX (ANTIGEN/PEPTIDE)
2aj3:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
2aj3:F (PRO149) to (SER215) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
2ak4:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:G (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:L (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:R (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
1nc2:B (PRO155) to (PRO218) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
4gw1:B (PRO155) to (PRO219) CQFD MEDITOPE | IGG, IMMUNE SYSTEM, EGFR
1a9b:B (ILE36) to (LYS95) DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS | MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE)
1a9b:E (ILE36) to (LYS95) DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS | MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE)
4wi3:A (ASP376) to (LEU443) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
1ngz:B (PRO150) to (PRO214) CHIMERIC GERMLINE FAB 7G12-APO | ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM
1agc:B (ILE35) to (LYS94) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1agf:B (ASP34) to (LYS94) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
2axg:B (ASP34) to (LYS94) THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION | IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX
3ru8:H (PRO151) to (PRO227) STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB | BINDING EPITOPE FROM HIV ON A HETEROLOGOUS PROTEIN, IMMUNE SYSTEM, DE NOVO PROTEIN
1nlb:H (PRO149) to (HIS199) CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6 | MURINE MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1aj7:H (VAL150) to (PRO213) IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY | GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY MATURATION, IMMUNOGLOBULIN
3rwc:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwc:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
1aqd:B (SER126) to (ARG189) HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE | COMPLEX (MHC PROTEIN/ANTIGEN), HISTOCOMPATIBILITY ANTIGEN
1aqd:H (SER126) to (ARG189) HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE | COMPLEX (MHC PROTEIN/ANTIGEN), HISTOCOMPATIBILITY ANTIGEN
4wrm:A (ASN428) to (ALA497) STRUCTURE OF THE HUMAN CSF-1:CSF-1R COMPLEX | CYTOKINE-CYTOKINE RECEPTOR COMPLEX
4hbc:H (PRO151) to (PRO212) CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS | FAB, RABBIT, CONFORMATION-SPECIFIC, AMYLOID, IMMUNE SYSTEM
2bck:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE | IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM
2bck:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE | IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM
4hfu:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4hg4:L (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4hg4:N (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4hg4:R (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3s3p:A (CYS620) to (ASN681) TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR | TRANSGLUTAMINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3eyo:B (PRO161) to (PRO225) CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 | HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3eyv:B (PRO155) to (PRO219) ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS | IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM
1bj1:K (PRO159) to (PRO223) VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY | COMPLEX (ANTIBODY/ANTIGEN), ANGIOGENIC FACTOR
2bnr:B (ILE35) to (LYS94) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES
4x6f:B (ILE35) to (LYS94) CD1A BINARY COMPLEX WITH SPHINGOMYELIN | CD1A, IMMUNE COMPLEX, LIPID ANTIGEN, TCR
4huv:E (ILE35) to (TYR94) CRYSTAL STRUCTURE OF H2DB-NPM6W | VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM
2bvq:B (ASP34) to (LYS94) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE
3sda:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE | CD1D, BETA-LINKED ANTIGEN, IMMUNITY, NKT, AUTOREACTIVE, IMMUNE SYSTEM
3sda:D (HIS157) to (TRP243) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE | CD1D, BETA-LINKED ANTIGEN, IMMUNITY, NKT, AUTOREACTIVE, IMMUNE SYSTEM
3sdd:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM
3sdd:D (HIS157) to (ALA242) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM
4xh2:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:G (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:J (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
2c1o:H (PRO149) to (PRO212) ENAIIHIS FAB FRAGMENT IN THE FREE FORM | FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENA11HIS ANTIBODY, IMMUNOGLOBULIN DOMAIN
1ce1:H (PRO157) to (GLU220) 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN | THERAPEUTIC, ANTIBODY, CD52, IMMUNE SYSTEM
4i48:B (ASP35) to (LYS95) STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV ENV DERIVED PEPTIDE | MONOMER, PEPTIDE PRESENTATION, IMMUNE SYSTEM
3sob:H (PRO149) to (PRO213) THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB | BETA PROPELLER, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
1clo:H (PRO149) to (PRO212) ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 | IMMUNOGLOBULIN, FAB-FRAGMENT
3fqr:B (ILE34) to (LYS93) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
4idj:H (PRO149) to (GLU212) S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB | HEMOLYSIN COMPLEX WITH FAB, CYTOLYTIC PROTEIN, FAB, SECRETED, IMMUNE SYSTEM
4xmp:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
1cz8:H (PRO159) to (PRO223) VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY | COMPLEX (ANTIBODY/ANTIGEN), CYSTINE KNOT, FAB FRAGMENT, IMMUNE SYSTEM
1p1z:A (ASP212) to (ARG273) X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB | NK, KB, MHC, ANTIGENIC PEPTIDE, LY49, OVA, IMMUNE SYSTEM
3g08:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM
1d5b:B (PRO149) to (PRO213) UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY | IMMUNE SYSTEM
1d5b:H (PRO149) to (PRO213) UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY | IMMUNE SYSTEM
4iih:A (GLY777) to (ALA855) CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE | TIM BARREL, HYDROLASE, HIGH-MANNOSE N-GLYCOSYLATIONS, EXTRACELLULAR
2ql1:A (ASP376) to (LEU443) STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT | ANTIBODY, ADCC, FC FRAGMENT, MUTATION, IMMUNE SYSTEM
1pg7:H (PRO149) to (PRO213) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
4irj:B (ILE35) to (TYR94) STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4irj:D (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
2qqp:E (TYR439) to (CYS506) CRYSTAL STRUCTURE OF AUTHENTIC PROVIDENCE VIRUS | VIRUS, CAPSID, COAT PROTEIN, PROTEIN-RNA COMPLEX, BETA BARREL, IG- LIKE DOMAIN, TETRAVIRUS, TETRAVIRIDAE, ICOSAHEDRAL VIRUS, QUASIEQUIVALENCE, AUTO-CATALYTIC CLEAVAGE, AUTO PROTEOLYSIS
4xx1:H (PRO162) to (PRO226) LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1 | A/B HYDROLASE, COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
3t5i:B (GLU72) to (VAL150) STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D | IMMUNOGLOBULIN-LIKE BETA SANDWITCH FOLD, RHEB, FARNESYL, PRENYL, SIGNALING PROTEIN, LIPID BINDING PROTEIN
3t5i:C (GLU72) to (TYR149) STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D | IMMUNOGLOBULIN-LIKE BETA SANDWITCH FOLD, RHEB, FARNESYL, PRENYL, SIGNALING PROTEIN, LIPID BINDING PROTEIN
3t5i:D (GLU72) to (VAL150) STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D | IMMUNOGLOBULIN-LIKE BETA SANDWITCH FOLD, RHEB, FARNESYL, PRENYL, SIGNALING PROTEIN, LIPID BINDING PROTEIN
3giz:H (PRO158) to (PRO222) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB | CD20, 2F2, OFATUMUMAB, HU-MAXCD20, FAB, ANTIBODY, FULLY HUMAN ANTIBODY, IMMUNE SYSTEM
3gjf:B (ILE35) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:E (ASP34) to (LYS94) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:H (PRO155) to (PRO219) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gkw:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY | IMMUNOGLOBULIN FOLD, DISPLACED STRICTLY CONSERVED TRP 103 FOLLOWING KABAT NUMBERING, IMMUNE SYSTEM, ANTITUMOR PROTEIN
3gml:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM
3gmo:B (ILE35) to (TYR94) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3tbt:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbt:E (HIS34) to (TYR94) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbt:H (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbt:K (HIS34) to (TYR94) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3gsn:L (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gso:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gsq:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4j6r:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, CD4-BINDING SITE, VRC23, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3tie:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB | ANTIGEN PRESENTATION, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM
3tie:E (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB | ANTIGEN PRESENTATION, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM
3tn0:D (GLU159) to (TRP243) STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX | MOUSE CD1D, MOUSE NKT, IMMUNE SYSTEM
4jfp:B (ILE35) to (LYS94) A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfp:E (ILE35) to (LYS94) A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfz:H (PRO149) to (PRO213) STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
2dyp:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G | IMMUNOGLOBULIN-LIKE, IMMUNE SYSTEM
4jo1:H (PRO149) to (PRO210) CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120 | IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jo1:I (PRO149) to (PRO210) CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120 | IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jo2:I (PRO145) to (PRO206) CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120 | IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3h42:L (THR150) to (ALA212) CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY | HYDROLASE, PROTEIN FAB COMPLEX, AUTOCATALYTIC CLEAVAGE, CHOLESTEROL METABOLISM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, LIPID METABOLISM, PHOSPHOPROTEIN, PROTEASE, SECRETED, SERINE PROTEASE, STEROID METABOLISM, ZYMOGEN, HYDROLASE-IMMUNE SYSTEM COMPLEX
4jrx:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
1qr1:B (ASP34) to (LYS94) POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE | PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM
1qr1:E (ASP34) to (LYS94) POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE | PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM
1qrn:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A | HUMAN TCR/PEPTIDE/MHC COMPLEX, HLA-A2, HTLV-1, TAX, TCR, T CELL RECEPTOR, IMMUNE SYSTEM
1f3j:B (LYS126) to (ARG189) HISTOCOMPATIBILITY ANTIGEN I-AG7 | HISTOCOMPATIBILITY ANTIGEN, MHC, PEPTIDE COMPLEX, IMMUNE SYSTEM
1f3j:E (LYS126) to (ARG189) HISTOCOMPATIBILITY ANTIGEN I-AG7 | HISTOCOMPATIBILITY ANTIGEN, MHC, PEPTIDE COMPLEX, IMMUNE SYSTEM
3h7b:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h7b:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3u2s:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109 | GREEK KEY, IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
1f4h:D (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC) | ALPHA/BETA BARREL, JELLY ROLL BARREL, FIBRONECTIN, BETA SUPERSANDWICH, HYDROLASE
4jzj:D (ASP133) to (VAL200) CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX | RECEPTOR-FAB COMPLEX, CYTOKINE RECEPTOR-IMMUNE SYSTEM COMPLEX
4jzj:H (PRO156) to (PRO220) CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX | RECEPTOR-FAB COMPLEX, CYTOKINE RECEPTOR-IMMUNE SYSTEM COMPLEX
4yny:D (ASP165) to (PRO229) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yo0:B (GLU167) to (PRO229) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PEPTIDES, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yo0:C (PRO172) to (PRO235) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PEPTIDES, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yo0:D (GLU167) to (PRO229) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PEPTIDES, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
2v2w:B (ILE35) to (LYS94) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT | IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE
2v2w:E (ILE35) to (LYS94) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT | IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE
1fl5:H (PRO149) to (PRO213) THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1fl5:B (PRO149) to (PRO213) THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
3hla:B (ILE35) to (LYS94) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 | HISTOCOMPATIBILITY ANTIGEN
1rjl:B (SER156) to (LYS216) STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831 | BETA SHEET, ANTIBODY-PROTEIN COMPLEX, IMMUNE SYSTEM
1rjy:B (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1rjy:E (HIS34) to (TYR94) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1fve:B (PRO156) to (PRO220) X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING | IMMUNOGLOBULIN
4yzf:G (PRO159) to (LYS219) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4yzf:I (PRO159) to (PRO222) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4yzf:K (PRO159) to (LYS219) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
2fd6:H (PRO144) to (ALA207) STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A | UPAR, ATF, ATN-615 ANTIBODY, FAB, TERNARY COMPLEX, IMMUNE SYSTEM, HYDROLASE
2vdm:H (PRO155) to (PRO218) RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX
3upr:B (ILE35) to (LYS94) HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR | HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM
3upr:D (ASP34) to (LYS94) HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR | HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM
4kjp:C (PRO157) to (PRO220) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kjp:E (PRO157) to (PRO220) STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE | MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN
4kk8:C (PRO157) to (PRO220) STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
3utq:B (ILE35) to (LYS94) HUMAN HLA-A*0201-ALWGPDPAAA | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, IMMUNE SYSTEM
1gc1:H (PRO164) to (PRO228) HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120, T-CELL SURFACE GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, GLYCOSYLATED PROTEIN, VIRAL PROTEIN- RECEPTOR-IMMUNE SYSTEM COMPLEX
3v0w:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS | BETA BARREL, ANTIBODY, FAB, IMMUNE SYSTEM
1s9v:B (ILE127) to (ALA190) CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE | IMMUNE SYSTEM, HLA-DQ2
3v5h:B (ILE35) to (LYS94) HLA-A2.1 KVAEIVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5h:E (ILE35) to (LYS94) HLA-A2.1 KVAEIVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
4kq3:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4kty:A (ASN662) to (ASP722) FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND | TRANSGLUTAMINASE, COAGULATION, TRANSFERASE, ACYLTRANSFERASE, LIGAND, CALCIUM IONS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4kty:B (ASN662) to (GLN726) FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND | TRANSGLUTAMINASE, COAGULATION, TRANSFERASE, ACYLTRANSFERASE, LIGAND, CALCIUM IONS, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2gaz:B (ILE35) to (TYR94) MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D | MYCOBACTERIA, NKT CELLS, TCR, CD1, LIPID ANTIGEN PRESENTATION, IMMUNE SYSTEM
4kxz:H (PRO156) to (HIS220) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
4kxz:N (PRO156) to (HIS220) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
4ky1:H (PRO157) to (LYS218) HUMANIZED HP1/2 FAB | FAB, ANTIBODY, ALPHA4 INTEGRIN, IMMUNE SYSTEM
4kze:H (PRO161) to (PRO225) CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IMMUNE SYSTEM-RNA COMPLEX
1h15:B (SER126) to (ALA190) X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE | IMMUNE SYSTEM/TRANSFERASE, COMPLEX (MHC/ANTIGEN), IMMUNE SYSTEM, MHC, HLA, CLASS II, DR2, DRB5, EBV, PEPTIDE, DNA POLYMERASE, DNA-DIRECTED DNA POLYMERASE
1t1y:B (ILE35) to (LYS94) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
4l29:B (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:D (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:F (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:H (ILE35) to (HIS84) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:J (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:L (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:N (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:R (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:T (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:V (ILE35) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:Z (ASP34) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:b (ASP34) to (LYS94) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
2gj6:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE | HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, T-CELL RECEPTOR A6, IMMUNE SYSTEM
4l3c:B (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:D (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:F (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:H (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:J (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:L (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:N (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:P (ILE35) to (HIS84) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:R (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:T (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:V (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:X (ASP34) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:Z (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:b (ILE35) to (LYS94) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
2vzu:A (GLY699) to (TRP766) COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA D469A WITH PNP-BETA-D-GLUCOSAMINE | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
2vzu:B (LEU700) to (TRP766) COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA D469A WITH PNP-BETA-D-GLUCOSAMINE | GH2, CSXA, PNP-GLUCOSAMINE, GLYCOSIDE HYDROLASE, EXO-BETA-D-GLUCOSAMINIDASE, HYDROLASE
2vzv:A (GLY699) to (TRP766) SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN | EXO-BETA-D-GLUCOSAMINIDASE, GH2, CSXA, CHITOSAN, GLYCOSIDE HYDROLASE, HYDROLASE
2vzv:B (LEU700) to (LYS770) SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN | EXO-BETA-D-GLUCOSAMINIDASE, GH2, CSXA, CHITOSAN, GLYCOSIDE HYDROLASE, HYDROLASE
3ifl:H (PRO156) to (LYS216) X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
4zpt:A (PRO149) to (PRO212) STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1) | VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4zpt:H (PRO149) to (PRO212) STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1) | VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2gt9:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gt9:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gtw:B (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gtw:E (ILE35) to (LYS94) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
3ilp:B (ILE35) to (TYR94) STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI | ANTIGEN PRESENTATION. INKT CELLS, GLYCOLIPID, HOST DEFENSE, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, IMMUNE SYSTEM
4zto:I (PRO148) to (PRO209) FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION | HIV-1, ENV, C4, CD4, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1tji:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE | 2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
2wbj:A (ASN118) to (PHE180) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
2wbj:B (SER126) to (TRP188) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
2wbj:F (SER126) to (ALA190) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
4zxb:C (PRO149) to (LYS208) STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES | RECEPTOR TYROSINE KINASE EXTRACELLULAR DOMAIN ANTIBODY FRAGMENTS, HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
3iu4:H (PRO149) to (PRO213) ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3 | ANTIBODY, GANGLIOSIDE, IDIOTYPE, IMMUNE SYSTEM
4zyp:J (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
4zyp:N (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
1hsa:B (ILE35) to (LYS94) THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC | HISTOCOMPATIBILITY ANTIGEN
1hsa:E (ILE35) to (LYS94) THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC | HISTOCOMPATIBILITY ANTIGEN
2hjl:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE | B57, HLA, HIV, IMMUNE SYSTEM
1i1f:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
1i1f:E (ASP34) to (TRP95) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
2hwz:H (PRO149) to (PRO213) FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM) | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM
2i69:A (CYS336) to (SER400) CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN | VIRAL MEMBRANE FUSION PROTEIN, RECEPTOR BINDING, ANTIBODY EPITOPE, IGC, BETA SANDWICH, GLYCOPROTEIN, VIRAL PROTEIN
1iqd:B (PRO150) to (ASP209) HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB. | FACTOR VIII, C2 DOMAIN, ANTIBODY, BLOOD COAGULATION, INHIBITOR, BO2C11, IMMUNE SYSTEM/BLOOD CLOTTING COMPLEX
2x05:A (GLY699) to (TRP766) INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE | EXO-BETA-D-GLUCOSAMINIDASE, GLYCOSIDE HYDROLASE, GH2, CSXA, HYDROLASE, GLYCOSIDASE
2x05:B (GLY699) to (TRP766) INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE | EXO-BETA-D-GLUCOSAMINIDASE, GLYCOSIDE HYDROLASE, GH2, CSXA, HYDROLASE, GLYCOSIDASE
1uwe:H (PRO149) to (PRO213) MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 | ANTIBODY
1uwe:V (PRO149) to (PRO213) MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 | ANTIBODY
1uwe:Y (PRO149) to (PRO213) MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 | ANTIBODY
1j0k:B (ASP35) to (THR98) CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE | BETA-ALPHA-BARRELS, HYDROLASE
3wii:H (PRO155) to (PRO218) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1. | IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM
2xa8:H (PRO157) to (VAL219) CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A | XOLAIR, ALLERGY, IMMUNE SYSTEM
4mng:B (HIS34) to (TYR94) STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE | IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
4mng:D (HIS34) to (TYR94) STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE | IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
1jf1:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A | HUMAN, TUMOR IMMUNITY, MELANOMA ANTIGEN, MHC, VACCINATION, MELANOMA, CLASS I, IMMUNE SYSTEM
3j5m:D (PRO149) to (PRO213) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j5m:H (PRO149) to (PRO213) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j5m:L (PRO149) to (PRO213) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1vgk:B (ILE35) to (LYS94) THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION | MHC, H-2KD, CRYSTAL STRUCTURE, CLASS I, IMMUNE SYSTEM
3wuw:B (ILE35) to (LYS94) KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T | IMMUNE RECEPTOR COMPLEX, PROTEIN BINDING
1juf:B (HIS1034) to (TYR1094) STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB | MHC CLASS-I, H2-DB, H13, MINOR HISTOCOMPATIBILITY ANTIGENS, IMMUNE SYSTEM
1w8n:A (LYS437) to (THR496) CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS. | GLYCOSIDASE, HYDROLASE, NEURAMINIDASE, BETA- PROPELLER FOLD.
1w99:A (ALA479) to (LEU557) MOSQUITO-LARVICIDAL TOXIN CRY4BA FROM BACILLUS THURINGIENSIS SSP. ISRAELENSIS | MEMBRANE PORE, BIO-INSECTICIDE, DIPTERAN SPECIFICITY, CONFORMATIONAL CHANGE, HYDROPHOBIC PATCH, TOXIN
5c0g:B (ILE35) to (LYS94) HLA-A02 CARRYING YLGGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
4nny:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | NONPHOSPHORYLATED EPITOPE, PEPTIDE-MHC COMPLEX, MHC, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, IMMUNE SYSTEM-ANTIGEN COMPLEX
4no3:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, PEPTIDE-MHC COMPLEX, MHC, TUMOR IMMUNOLOGY, PEPTIDE CONFORMATION, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
2yez:B (LYS33) to (ASP95) COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE | IMMUNE SYSTEM, BF21, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I
4nwt:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531 | BETA SANDWICH, HUMAN BETA NERVE GROWTH FACTOR, IMMUNE SYSTEM
1ktd:D (ASN153) to (TRP215) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, CYTOCHROME, IMMUNE SYSTEM
5c7x:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
4o5i:R (GLY142) to (PRO208) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3jts:B (ILE35) to (LYS94) GY9-MAMU-A*02-HB2M | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1xgt:B (PRO149) to (LYS209) STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33L MUTANT, IMMUNE SYSTEM
2nxy:D (PRO3164) to (PRO3228) HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjs:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114 | HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjs:F (PRO151) to (PRO227) CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114 | HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1lnu:A (VAL117) to (PRO181) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, SUGAR BINDING PROTEIN
1lnu:C (VAL117) to (PRO181) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, SUGAR BINDING PROTEIN
1lnu:E (VAL117) to (PRO181) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, SUGAR BINDING PROTEIN
1lnu:G (VAL117) to (PRO181) CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE | PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, SUGAR BINDING PROTEIN
1lo4:H (PRO154) to (LYS214) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9 | FAB, CATALYTIC ANTIBODY, RETRO-DEILS-ALDERASE, IMMUNE SYSTEM
2z93:C (PRO149) to (PRO212) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD | IMMUNOGLOBURIN LIKE FOLD, IMMUNE SYSTEM
4oly:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54R, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ono:A (ILE35) to (LYS94) CD1C IN COMPLEX WITH PM (PHOSPHOMYCOKETIDE) | IG FOLD, CD1C, ANTIGEN PRESENTATION, TCR, IMMUNE SYSTEM
1mfe:H (PRO404) to (PRO467) RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT | IMMUNOGLOBULIN
1mhe:B (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC
1mhe:D (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC
4p2q:B (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2q:E (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2q:G (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2q:L (ASN126) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p2q:Q (ILE127) to (LYS189) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
4p59:H (PRO153) to (GLU216) HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825 | HER3 RECEPTOR, THERAPEUTIC ANTIBODY, FAB FRAGMENT, ANTI-HER3, SIGNALING PROTEIN, IMMUNE SYSTEM
3kpp:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN | HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
5d6c:H (PRO148) to (PRO212) STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT | STAPHYLOCOCCUS AUREUS WALL TEICHOIC ACID ANTIBODY MRSA, IMMUNE SYSTEM
4p9m:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 8ANC195 FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
1yef:H (PRO149) to (PRO223) STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE | CATALYTIC ANTIBODY
1yeh:H (PRO149) to (PRO223) STRUCTURE OF IGG2A FAB FRAGMENT | CATALYTIC ANTIBODY, IMMUNOGLOBULIN C REGION
1ymh:D (PRO149) to (LYS209) ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W | ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM
3kxf:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3kxf:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3kxf:J (ILE35) to (LYS94) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5dd6:A (PRO149) to (ILE213) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
5def:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE | IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2704
4pg2:C (ILE35) to (TRP95) THE CRYSTAL STRUCTURE OF H-2DB WITH A S-GLUTATHIONYLATED PEPTIDE | IMMUNE RECEPTOR, GLUTATHIONYLATED PEPTIDE, T CELL BIOLOGY, ANTIGEN PRESENTATION, IMMUNE SYSTEM
1ypz:B (ILE35) to (LYS94) IMMUNE RECEPTOR | H2-T22 PROTEIN, BETA-2-MICROGLOBULIN, T CELL RECEPTOR DELTA, T-CELL RECEPTOR GAMMA CHAIN, IMMUNE SYSTEM
1ypz:D (ASP34) to (LYS94) IMMUNE RECEPTOR | H2-T22 PROTEIN, BETA-2-MICROGLOBULIN, T CELL RECEPTOR DELTA, T-CELL RECEPTOR GAMMA CHAIN, IMMUNE SYSTEM
4pj5:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR | MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM
4pj5:F (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR | MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM
4pj9:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pja:B (ILE35) to (LYS94) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pja:D (ILE35) to (HIS84) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
1yuk:B (VAL368) to (PRO421) THE CRYSTAL STRUCTURE OF THE PSI/HYBRID DOMAIN/ I-EGF1 SEGMENT FROM THE HUMAN INTEGRIN BETA2 AT 1.8 RESOLUTION | INTEGRIN BETA2, HYBRID DOMAIN, PSI DOMAIN, I-EGF DOMAIN, CRYSTAL STRUCTURE OF PSI/HYBRID/I-EGF1, CELL ADHESION
4plk:H (PRO159) to (PRO222) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plk:J (PRO159) to (PRO222) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4prb:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4prd:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4prp:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
1za3:B (PRO149) to (PRO213) THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
5drn:H (PRO149) to (ALA209) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU24, EIF5A, IMMUNE SYSTEM
5dtf:H (PRO149) to (PRO210) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU98.61, EIF5A, IMMUNE SYSTEM
5dtf:A (PRO149) to (PRO210) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU98.61, EIF5A, IMMUNE SYSTEM
5dum:H (PRO163) to (LYS223) CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 65C6 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
3lkq:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3lks:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1zls:H (PRO151) to (PRO227) FAB 2G12 + MAN4 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN-SWAPPING, IMMUNE SYSTEM
1zs8:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:F (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:H (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:J (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zt4:B (ILE35) to (LYS94) THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE | HUMAN CD1D, CD1, MHC CLASS I, EMPTY BINDING GROOVE, GLYCOLIPID, ALPHA-GALACTOSYLCERAMIDE, ALPHA-GALCER, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, IMMUNE SYSTEM
1zt4:D (ILE35) to (LYS94) THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE | HUMAN CD1D, CD1, MHC CLASS I, EMPTY BINDING GROOVE, GLYCOLIPID, ALPHA-GALACTOSYLCERAMIDE, ALPHA-GALCER, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, IMMUNE SYSTEM
5e2u:H (PRO149) to (PRO213) STRUCTURE OF ANTI-TAU AT8 FAB IN THE PRESENCE OF PHOSPHOPEPTIDE | IMMUNE SYSTEM
5e8f:A (GLU72) to (VAL150) STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D | PRENYL BINDING PROTEIN, IMMUNOGLOBULIN-LIKE BETA SANDWITCH FOLD, GERANYLGERANYL, HYDROLASE
5e8f:C (PHE74) to (VAL150) STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D | PRENYL BINDING PROTEIN, IMMUNOGLOBULIN-LIKE BETA SANDWITCH FOLD, GERANYLGERANYL, HYDROLASE
3lzf:H (PRO151) to (LYS221) CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, PANDEMIC FLU, SWINE FLU, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, ANTIGEN, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2a47:A (THR143) to (ALA221) CRYSTAL STRUCTURE OF AMFP486 H199T | BETA BARREL, LUMINESCENT PROTEIN
5eds:A (LEU379) to (LEU467) CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH BENZIMIDAZOLE INHIBITOR 5 | INHIBITOR, PHOSPHOTRANSFERASE, P110, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2adf:H (PRO154) to (LYS214) CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN | ON WILLEBRAND FACTOR, A3-DOMAIN, 82D6A3, COLLAGEN BINDING, PARATOPE, EPITOPE, ANTITHROMBOTIC, BLOOD CLOTTING-IMMUNE SYSTEM COMPLEX
5en2:A (PRO149) to (LYS209) MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES | IMMUNOGLOBULIN, GLYCOPROTEIN, VIRUS, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3bh9:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM
3bhb:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM
5eu6:B (ILE35) to (LYS94) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5euk:B (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3mrc:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mro:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1
3mv8:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG | HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM
3mv8:E (HIS164) to (ASP254) CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG | HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM
5f2u:B (GLU72) to (VAL150) STRUCTURE OF FULLY MODIFIED FARNESYLATED INPP5E PEPTIDE IN COMPLEX WITH PDE6D | LIPID BINDING PROTEIN, IMMUNOGLOBULIN-LIKE, SIGNALING PROTEIN
5f3b:A (PRO152) to (PRO216) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3b:E (PRO152) to (PRO216) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f6i:C (ALA147) to (PRO212) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH428 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3myz:A (ASP34) to (LYS94) PROTEIN INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T | AMYLOID, THIOFLAVIN T, PARKINSON'S, ALZHEIMER'S, BETA-2 MICROGLOBULIN, IMMUNE SYSTEM
3bwa:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN | HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3bzf:B (ILE35) to (ARG97) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | MHC FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, HOST-VIRUS INTERACTION, UBL CONJUGATION, IMMUNE SYSTEM
3bzf:D (ILE35) to (LYS94) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | MHC FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, HOST-VIRUS INTERACTION, UBL CONJUGATION, IMMUNE SYSTEM
3c09:C (PRO157) to (LYS218) CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR | CELL SURFACE RECEPTOR, GLYCOPROTEIN, ANTIGEN, ANTIBODY COMPLEX, FAB FRAGMENT, ANTITUMOR, DRUG IMMUNE SYSTEM-TRANSFERASE COMPLEX, IMMUNE SYSTEM-TRANSFERASE COMPLEX
5fb8:B (PRO177) to (PRO241) STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY | CYTOKINE, INTERLEUKIN, ANTIBODY, COMPLEX, IMMUNE SYSTEM
4r2g:Q (PRO167) to (PRO231) CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4 | PROTEIN-PROTEIN COMPLEX, IGG, ANTI-HIV ANTIBODIES, GP120, IMMUNE SYSTEM
5fec:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
3naa:H (PRO149) to (ARG210) CRYSTAL STRUCTURE OF FAB15 MUT5 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
5fkp:B (ILE35) to (TYR94) CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE | IMMUNE SYSTEM, CD1D, ANTIGEN PRESENTATION, ALPHA-HELICAL
3ckh:B (GLU92) to (PHE172) CRYSTAL STRUCTURE OF EPH A4 RECEPTOR | EPH RECEPTOR, ATP-BINDING, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3o2d:H (PRO149) to (SER213) CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY | IMMUNOGLOBULIN FOLD, HIV-1 PRIMARY RECEPTOR, T CELL CORECEPTOR, MONOCLONAL ANTIBODY, MEMBRANE, IMMUNE SYSTEM
4rwy:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY 8ANC131, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4s1r:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H08.F-117225, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE | HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
3d2u:B (ILE35) to (LYS94) STRUCTURE OF UL18, A PEPTIDE-BINDING VIRAL MHC MIMIC, BOUND TO A HOST INHIBITORY RECEPTOR | MHC CLASS I HOMOLOG, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, MEMBRANE, PHOSPHOPROTEIN, RECEPTOR, TRANSMEMBRANE, IMMUNE SYSTEM
3d2u:F (ASP34) to (LYS94) STRUCTURE OF UL18, A PEPTIDE-BINDING VIRAL MHC MIMIC, BOUND TO A HOST INHIBITORY RECEPTOR | MHC CLASS I HOMOLOG, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, MEMBRANE, PHOSPHOPROTEIN, RECEPTOR, TRANSMEMBRANE, IMMUNE SYSTEM
3d39:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE | HTLV-1 TAX PEPTIDE, 4-FLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T- CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3d87:B (ASP129) to (PHE205) CRYSTAL STRUCTURE OF INTERLEUKIN-23 | INTERLEUKIN-23, FAB, CYTOKINE
3d87:D (ASP129) to (PHE205) CRYSTAL STRUCTURE OF INTERLEUKIN-23 | INTERLEUKIN-23, FAB, CYTOKINE
5ggt:H (PRO159) to (PRO223) PD-L1 IN COMPLEX WITH BMS-936559 FAB | ANTIBODY, IMMUNE SYSTEM
4d0d:A (PRO208) to (TRP270) COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE | IMMUNE SYSTEM
4d0d:D (PRO208) to (SER269) COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE | IMMUNE SYSTEM
4d0d:G (PRO208) to (TRP270) COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE | IMMUNE SYSTEM
4tsc:H (PRO149) to (PRO213) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
4tsc:L (THR145) to (PRO208) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
3dgg:D (PRO155) to (PRO218) CRYSTAL STRUCTURE OF FABOX108 | ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4ttg:B (ARG255) to (ASP329) BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE. | GLYCOSIDASE, (ALPHA/BETA)8 BARREL, JELLY ROLL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, COMPLEX WITH POTASSIUM, HYDROLASE
5h4z:A (GLY142) to (PRO213) CRYSTAL STRUCTURE OF S202G MUTANT OF HUMAN SYT-5 C2A DOMAIN | METAL BINDING PROTEIN, MUTANT
4u0r:B (PRO158) to (LYS218) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY 9AD4 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
4d9q:E (PRO157) to (PRO221) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
3ov6:A (ILE1035) to (LYS1094) CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE) | MHC, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION
5hhm:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhm:G (ASP34) to (LYS94) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhp:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
3p4n:B (HIS34) to (TYR94) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV | H2-KB, PV, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
4dn4:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A | ANTIBODY CHEMOKINE, IMMUNE SYSTEM
5hys:H (PRO157) to (PRO221) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
5hys:A (PRO157) to (PRO221) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
5i1a:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1a:B (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1k:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4duw:C (ARG255) to (ASP329) E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE | BI-FUNCTIONAL ENZYME, ALLOLACTOSE SYNTHESIS, TIM BARREL (ALPHA/BETA BARREL), JELLY-ROLL BARREL, IMMUNOGLOBULIN, BETA SUPERSANDWICH, BETA-GALACTOSIDASE, GLYCOSIDASE, HYDROLASE
3piq:L (VAL144) to (PRO208) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
3piq:B (ALA143) to (PRO208) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
3piq:I (GLY142) to (PRO208) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
5ind:B (ASP34) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_E5D, IMMUNE SYSTEM
5ind:D (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_E5D, IMMUNE SYSTEM
3qeq:B (ASP34) to (LYS94) THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3qg7:H (PRO151) to (PRO227) STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY | IMMUNOGLOBULIN FOLD, ANTIGEN RECOGNITION, AIP4, SECRETED, IMMUNE SYSTEM
4f9p:A (LEU36) to (LEU117) CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY | B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM
3qul:B (HIS34) to (TYR94) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE
3qul:H (HIS34) to (TYR94) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE
3quy:B (ILE35) to (TYR94) STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3quz:B (ILE35) to (TYR94) STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4fqq:C (THR146) to (PRO209) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
3rhw:K (THR148) to (SER210) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3rhw:O (VAL146) to (SER208) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
5jr1:L (THR146) to (ALA208) CRYSTAL STRUCTURE OF 10E8 GHV-MATUREL ANTIGEN-BINDING FRAGMENT. | MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM
4g7y:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:A (PRO160) to (PRO224) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:C (PRO160) to (PRO224) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:E (PRO160) to (PRO224) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g80:G (PRO160) to (PRO224) CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A) | MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE
4g8i:B (ILE35) to (LYS94) CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
5kzc:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM
5th2:B (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM